SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 

For the month of August, 2017

Commission File Number 1565025

 

 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

  Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 
 

 

INTERIM CONSOLIDATED FINANCIAL STATEMENTS - AMBEV S.A.

 

Interim Consolidated Balance Sheets

As at June 30, 2017 and December 31, 2016

(Expressed in thousands of Brazilian Reais)

 

Assets

Note

06/30/2017

12/31/2016

       

Cash and cash equivalents

5

8,757,342

7,876,849

Investment securities

6

8,770

282,771

Derivative financial instruments

21

259,577

196,655

Trade receivable

 

3,572,196

4,368,059

Inventories

7

4,663,951

4,347,052

Income tax and social contributions recoverable

 

3,852,294

4,693,724

Other taxes receivable

 

676,845

729,586

Other assets

 

1,251,873

1,392,155

Current assets

 

23,042,848

23,886,851

       

Investment securities

6

94,475

104,340

Derivative financial instruments

21

29,849

16,326

Income tax and social contributions recoverable

 

-

4,493

Other taxes recoverable

 

345,921

343,147

Deferred tax assets

8

3,246,697

2,268,142

Other assets

 

2,049,864

1,973,584

Employee benefits

 

33,713

33,503

Investments in associates

 

306,635

300,115

Property, plant and equipment

9

18,638,073

19,153,836

Intangible assets

 

5,239,605

5,245,881

Goodwill

10

31,096,331

30,511,200

Non-current assets

 

61,081,163

59,954,567

       

Total assets

 

84,124,011

83,841,418

 

 

 

 

 

1


 
 

 

Interim Consolidated Balance Sheets (continued)

As at June 30, 2017 and December 31, 2016

(Expressed in thousands of Brazilian Reais)

 

Equity and liabilities

Note

06/30/2017

12/31/2016

       

Trade payables

 

9,123,481

10,868,757

Derivative financial instruments

21

195,380

686,358

Interest-bearing loans and borrowings

11

3,590,840

3,630,604

Bank overdrafts

5

27,061

-

Wages and salaries

 

799,488

686,627

Dividends and interest on shareholders’ equity payable

 

3,139,950

1,714,401

Income tax and social contribution payable

 

1,026,736

904,240

Taxes and contributions payable

 

2,024,276

3,378,178

Put option granted on subsidiary and other liabilities

 

5,920,044

6,735,849

Provisions

12

168,725

168,636

Current liabilities

 

26,015,981

28,773,650

       

Trade payables

 

186,741

237,802

Derivative financial instruments

21

2,975

27,022

Interest-bearing loans and borrowings

11

1,326,796

1,765,706

Deferred tax liabilities

8

2,264,462

2,329,722

Taxes and contributions payable

 

735,750

681,424

Put option granted on subsidiary and other liabilities

 

767,440

471,792

Provisions

12

889,488

765,370

Employee benefits

 

2,202,316

2,137,657

Non-current liabilities

 

8,375,968

8,416,495

       

Total liabilities

 

34,391,949

37,190,145

       

Equity

13

   

Issued capital

 

57,614,140

57,614,140

Reserves

 

64,284,124

64,230,028

Carrying value adjustments

 

(75,828,400)

(77,019,120)

Retained earnings

 

1,699,355

-

Equity attributable to equity holders of Ambev

 

47,769,219

44,825,048

Non-controlling interests

 

1,962,843

1,826,225

Total Equity

 

49,732,062

46,651,273

       

Total equity and liabilities

 

84,124,011

83,841,418

 

 

The accompanying notes are an integral part of these interim consolidated financial statements.

 

 

 

 

 

 

2


 
 

 

Interim Consolidated Income Statements

For the six and three-month period ended June 30, 2017 and 2016

(Expressed in thousands of Brazilian Reais)

 

   

Six-month period ended:

 

Three-month period ended:

 

Note

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

             

Net sales

15

21,509,758

21,942,302

 

10,267,953

10,377,204

Cost of sales

 

(8,571,330)

(7,854,921)

 

(4,048,189)

(3,894,605)

Gross profit

 

12,938,428

14,087,381

 

6,219,764

6,482,599

             

Distribution expenses

 

(2,978,712)

(2,972,943)

 

(1,467,268)

(1,457,812)

Sales and marketing expenses

 

(2,797,142)

(3,029,420)

 

(1,383,356)

(1,481,543)

Administrative expenses

 

(1,076,439)

(1,087,189)

 

(520,780)

(553,551)

Other operating income/(expenses), net

16

513,396

723,467

 

222,570

331,132

Exceptional items

17

(60,779)

(28,465)

 

(32,085)

(22,226)

Income from operations

 

6,538,752

7,692,831

 

3,038,845

3,298,599

             

Finance cost

18

(1,817,950)

(2,529,448)

 

(821,692)

(1,035,991)

Finance income

18

246,533

458,260

 

122,870

136,108

Net finance cost

 

(1,571,417)

(2,071,188)

 

(698,822)

(899,883)

             

Share of results of associates

 

6,301

7,837

 

5,269

388

Income before income tax

 

4,973,636

5,629,480

 

2,345,292

2,399,104

             

Income tax expense

19

(558,972)

(562,966)

 

(220,459)

(226,583)

Net income

 

4,414,664

5,066,514

 

2,124,833

2,172,521

             

Attributable to:

           

Equity holders of Ambev

 

4,212,283

4,813,019

 

2,013,148

2,046,154

Non-controlling interests

 

202,381

253,495

 

111,685

126,367

             

Basic earnings per share – common - R$

 

0.27

0.31

 

0.13

0.13

Diluted earnings per share – common - R$

 

0.27

0.30

 

0.13

0.13

 

The accompanying notes are an integral part of these interim consolidated financial statements.

 

 

3


 
 

 

Interim Consolidated Statements of Comprehensive Income

For the six and three-month period ended June 30, 2017 and 2016

(Expressed in thousands of Brazilian Reais)

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

           

Net income

4,414,664

5,066,514

 

2,124,833

2,172,521

           

Items that will not be reclassified to profit or loss:

         

Full recognition of actuarial gains/(losses)

159,769

1,152

 

642

579

           

Items that may be reclassified subsequently to profit or loss:

         

Exchange differences on translation of foreign operations (gains/(losses)

         

Investment hedge in foreign operations

-

(23,331)

 

-

(46,619)

Investment hedge - put option granted on subsidiary

8,055

712,346

 

(120,737)

352,457

Gains/losses on translation of other foreign operations

752,054

(4,624,929)

 

1,363,653

(2,674,730)

Gains/losses on translation of foreign operations

760,109

(3,935,914)

 

1,242,916

(2,368,892)

           

Cash flow hedge - gains/(losses)

         

Recognized in Equity (Hedge reserve)

(6,255)

(681,582)

 

89,859

(308,191)

Removed from Equity (Hedge reserve) and included in profit or loss

306,049

(518,640)

 

102,708

(243,725)

Total cash flow hedge

299,794

(1,200,222)

 

192,567

(551,916)

           

Other comprehensive (loss)/income

1,219,672

(5,134,984)

 

1,436,125

(2,920,229)

           

Total comprehensive income

5,634,336

(68,470)

 

3,560,958

(747,708)

           

Attributable to:

         

Equity holders of Ambev

5,406,084

125,178

 

3,381,366

(621,253)

Non-controlling interest

228,252

(193,648)

 

179,592

(126,455)

 

 

The accompanying notes are an integral part of these interim consolidated financial statements. The consolidated statements of comprehensive income are presented net of income tax. The income tax effects of these items are disclosed in note 8 - Deferred income tax and social contribution.

 

 

 

4


 
 

 

Interim Consolidated Statements of Changes in Equity

For the six-month period ended June 30, 2017 and 2016

(Expressed in thousands of Brazilian Reais)

 

 

Attributable to equity holders of Ambev

     
 

Capital

Capital
reserves

Net income reserves

Retained
earnings

Carrying value adjustments

Total

 

Non-controlling interests

Total equity

At January 1, 2017

57,614,140

54,529,780

9,700,248

-

(77,019,120)

44,825,048

 

1,826,225

46,651,273

                   

Net Income

-

-

-

4,212,283

-

4,212,283

 

202,381

4,414,664

                   

Comprehensive income:

                 

Gains/(losses) on translation of foreign operations

-

-

-

-

732,889

732,889

 

27,220

760,109

Cash flow hedges

-

-

-

-

301,096

301,096

 

(1,302)

299,794

Actuarial gain/(losses)

-

-

-

-

159,816

159,816

 

(47)

159,769

Total comprehensive income

-

-

-

4,212,283

1,193,801

5,406,084

 

228,252

5,634,336

Gains/(losses) of controlling interest´s share

-

-

-

-

(3,081)

(3,081)

 

31,613

28,532

Dividends distributed

-

-

-

(2,513,077)

-

(2,513,077)

 

(123,247)

(2,636,324)

Acquired shares and result on treasury shares

-

18,413

-

-

-

18,413

 

-

18,413

Share-based payment

-

35,683

-

-

-

35,683

 

-

35,683

Prescribed dividends

-

-

-

149

-

149

 

-

149

At June 30, 2017

57,614,140

54,583,876

9,700,248

1,699,355

(75,828,400)

47,769,219

 

1,962,843

49,732,062

 

The accompanying notes are an integral part of these interim consolidated financial statements.

 

 

 

 

5


 
 

 

Interim Consolidated Statements of Changes in Equity (continued)

For the six-month period ended June 30, 2017 and 2016

(Expressed in thousands of Brazilian Reais)

 

 

Attributable to equity holders of Ambev

     
 

Capital

Capital
reserves

Net income reserves

Retained
earnings

Carrying value adjustments

Total

 

Non-controlling interests

Total equity

At January 1, 2016

57,614,140

54,373,451

8,201,323

-

(71,857,031)

48,331,883

 

2,001,750

50,333,633

                   

Net Income

-

-

-

4,813,019

-

4,813,019

 

253,495

5,066,514

                   

Comprehensive income:

                 

Losses on translation of foreign operations

-

-

-

-

(3,486,740)

(3,486,740)

 

(449,174)

(3,935,914)

Cash flow hedges

-

-

-

-

(1,202,253)

(1,202,253)

 

2,031

(1,200,222)

Actuarial gains

-

-

-

-

1,152

1,152

 

-

1,152

Total Comprehensive income

-

-

-

4,813,019

(4,687,841)

125,178

 

(193,648)

(68,470)

Put option granted on subsidiary

-

-

-

-

(144,079)

(144,079)

 

-

(144,079)

Gains/(losses) of controlling interest´s share

-

-

-

-

(9,175)

(9,175)

 

53,674

44,499

Dividends distributed

-

-

-

(2,040,800)

-

(2,040,800)

 

(100,164)

(2,140,964)

Interest on shareholders’ equity

-

-

(2,039,171)

-

-

(2,039,171)

 

-

(2,039,171)

Acquired shares and result on treasury shares

-

88,335

-

-

-

88,335

 

-

88,335

Share-based payment

-

(11,850)

-

-

-

(11,850)

 

-

(11,850)

Prescribed dividends

-

-

-

686

-

686

 

-

686

At June 30, 2016

57,614,140

54,449,936

6,162,152

2,772,905

(76,698,126)

44,301,007

 

1,761,612

46,062,619

 

The accompanying notes are an integral part of these interim consolidated financial statements.

 

 

 

 

 

6


 
 

 

Interim Consolidated Cash Flow Statements

For the six and three-month period ended June 30, 2017 and 2016

(Expressed in thousands of Brazilian Reais)

 

   

Six-month period ended:

 

Three-month period ended:

 

Note

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

             

Net income

 

4,414,664

5,066,514

 

2,124,833

2,172,521

Depreciation, amortization and impairment

 

1,699,965

1,747,666

 

872,395

883,831

Impairment losses on receivables and inventories

 

70,810

71,908

 

42,579

47,724

Additions/(reversals) in provisions and employee benefits

 

73,294

150,166

 

24,180

59,325

Net finance cost

18

1,571,417

2,071,188

 

698,822

899,883

Losses/(gain) on sale of property, plant and equipment and intangible assets

 

(2,689)

(28,170)

 

(8,065)

(25,256)

Equity-settled share-based payment expense

20

86,382

85,549

 

41,432

47,591

Income tax expense

19

558,972

562,966

 

220,459

226,583

Share of result of associates

 

(6,301)

(7,837)

 

(5,269)

(388)

Other non-cash items included in the profit

 

187,116

(709,625)

 

63,643

(245,054)

Cash flow from operating activities before changes in working capital and use of provisions

 

8,653,630

9,010,325

 

4,075,009

4,066,760

             

(Increase)/decrease in trade and other receivables

 

1,060,883

638,122

 

(377,432)

(383,433)

(Increase)/decrease in inventories

 

(285,716)

(410,975)

 

(85,769)

272,567

Increase/(decrease) in trade and other payables

 

(3,902,680)

(4,506,477)

 

(1,194,736)

(1,483,097)

Cash generated from operations

 

5,526,117

4,730,995

 

2,417,072

2,472,797

             

Interest paid

 

(250,939)

(464,309)

 

(95,787)

(318,534)

Interest received

 

136,042

407,902

 

80,748

363,253

Dividends received

 

3,959

25,101

 

54

5,277

Income tax paid

 

(1,006,049)

(4,832,630)

 

22,547

(440,916)

Cash flow from operating activities

 

4,409,130

(132,941)

 

2,424,634

2,081,877

             

Proceeds from sale of property, plant and equipment and intangible assets

 

25,803

48,780

 

15,270

33,201

Acquisition of property, plant and equipment and intangible assets

 

(1,310,539)

(1,858,539)

 

(751,040)

(1,151,255)

Acquisition of subsidiaries, net of cash acquired

 

(331,441)

(1,832,871)

 

1,289

(137,743)

Investment in short term debt securities and net proceeds/(acquisition) of debt securities

 

291,156

(39,490)

 

18,601

(61,451)

Net proceeds/(acquisition) of other assets

 

1,558

104

 

-

17

Cash flow from investing activities

 

(1,323,463)

(3,682,016)

 

(715,880)

(1,317,231)

             

Proceeds/(repurchase) of treasury shares

 

(32,768)

(4,541)

 

15,607

(5,005)

Proceeds from borrowings

 

2,594,314

903,223

 

1,356,139

130,107

Repayment of borrowings

 

(2,943,061)

(535,530)

 

(1,460,251)

(308,008)

Cash net of finance costs other than interests

 

(718,059)

(1,936,963)

 

(288,198)

(794,192)

Payment of finance lease liabilities

 

(4,491)

(1,557)

 

(2,223)

(750)

Dividends and Interest on shareholders’ equity paid

 

(1,214,998)

(2,186,030)

 

(82,979)

(86,381)

Cash flow from financing activities

 

(2,319,063)

(3,761,398)

 

(461,905)

(1,064,229)

             

Net increase/(decrease) in cash and cash equivalents

 

766,604

(7,576,355)

 

1,246,849

(299,583)

Cash and cash equivalents less bank overdrafts at beginning of year (i)

 

7,876,849

13,617,622

 

7,229,143

6,007,322

Effect of exchange rate fluctuations

 

86,828

(488,974)

 

254,289

(155,446)

Cash and cash equivalents less bank overdrafts at end of year (i)

 

8,730,281

5,552,293

 

8,730,281

5,552,293

 

(i) Net of bank overdrafts.

 

The accompanying notes are an integral part of these interim consolidated financial statements .

 

 

7


 
 

 

Notes to the interim consolidated financial statements:

1.

Corporate information

2.

Statement of compliance

3.

Summary of significant accounting policies

4.

Use of estimates and judgments

5.

Cash and cash equivalents

6.

Investment securities

7.

Inventories

8.

Deferred income tax and social contribution

9.

Property, plant and equipment

10.

Goodwill

11.

Interest-bearing loans and borrowings

12.

Provisions

13.

Changes in equity

14.

Segment reporting

15.

Net Sales

16.

Other operating income/(expenses)

17.

Exceptional items

18.

Finance cost and income

19.

Income tax and social contribution

20.

Share-based payments

21.

Financial instruments and risks

22.

Collateral and contractual commitments, advances from customers and other

23.

Contingencies

24.

Non-cash items

25.

Related parties

26.

Events after the reporting period

 

 

 

8


 
 

 

1.     CORPORATE INFORMATION

 

(a)      Description of business

 

Ambev S.A. ( referred to as the “Company” or “Ambev”), headquartered in São Paulo, Brazil, produces and sells beer, draft beer, soft drinks, other non-alcoholic beverages, malt and food in general.

 

The Company’s shares and ADR’s (American Depositary Receipts) are listed on the B3 S.A.- Brasil, Bolsa, Balcão as “ABEV3” and on the New York Stock Exchange (NYSE) as “ABEV”.

 

The Company’s direct controlling shareholders are Interbrew International B.V. (“IIBV”), AmBrew S.A. (“Ambrew”), both subsidiaries of Anheuser-Busch InBev N.V. (“AB InBev”) and Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência (“Fundação Zerrenner”).

 

The interim financial statements were approved by the Board of Directors on July 26, 2017.

 

(b)    Major corporate events in 2016 and 2017:

On May 16th, 2017, the Board of Directors of Ambev approved the execution, by and between the Company, or its controlled entities, and financial institutions to be approved by the Board of Officers, of equity swaps, having as underlying asset the shares issued by the Company or American Depositary Receipts representing these shares (“ADRs”). The settlement of the equity swap will take place within a maximum period of 18 months from this date, and the agreements may result in an exposure of up to 80 million common shares (of which all or part may be through ADRs), with a limit value of up to R$ 1.5 billion.

In December 2016, we acquired Cachoeira de Macacu Bebidas Ltda. from Brasil Kirin Indústria de Bebidas Ltda., a company that owns an operating industrial plant for the production and packaging of beer and non-alcohol  beverages  in the State of Rio de Janeiro for R$478,621.

 

On May 12, 2016, Ambev and its controlling shareholder, AB InBev, entered into an agreement for the exchange of shareholdings (“Swap”). The execution of the Swap was conditional on the implementation of the merger of the activities of AB InBev and SABMiller Plc (“SABMiller”), which occurred on October 10, 2016. Subsequently, on December 31, 2016, after the implementation of certain preparatory corporate acts, the Swap was effected. Based on the agreement described above, Ambev transferred to AB InBev the equity interest in Keystone Global Corporation - KGC, which held shares in companies domiciled in Colombia, Peru and Ecuador. On the other hand, AB InBev transferred to Ambev its interest in Cerveceria Nacional S. de R.L., a subsidiary domiciled in Panama, which had previously been acquired as a third party.

The value attributed to the transaction is based on a fairness opinion prepared by a specialized company and duly approved by the Board of Directors of Ambev, with abstention from the vote of the directors appointed by AB InBev.

 

 

 

9


 
 

 

The result of the transaction above mentioned was R$1,236,824, of which R$1,239,972 was recognized in the income statement on exceptional items.

 

On April, 2016, the Company, through its wholly-owned subsidiary Labatt Breweries, in Canada, acquired the company Archibald Microbrasserie, known for its local beers and seasonal specialties. Furthermore, in Brazil, acquired 66% of the company Sucos do Bem, which has a range of juices, teas and cereal bars. The acquisition amount added was approximately R$155 million.

On January, 2016, Ambev, through its wholly-owned subsidiaries, CRBS S.A. and Ambev Luxembourg, acquired companies to a range of primarily spirit­-based beers and ciders from Mark Anthony Group, by R$1.4 billion.

 

2.     STATEMENT OF COMPLIANCE

 

The consolidated financial statements have been prepared using the accounting basis of going concern and are being presented in accordance with IAS 34 - Interim Financial Reporting as issued by the International Accounting Standards Board (“IASB”).

 

The information does not meet all disclosure requirements for the presentation of full annual financial statements and thus should be read in conjunction with the consolidated financial statements prepared in accordance with International Financial Reporting Standards (“IFRS”) for the year ended December 31, 2016. To avoid duplication of disclosures which are included in the annual financial statements, the following notes were not subject to full filling:

 

(a)     Summary of significant accounting policies (Note 3);

(b)    Exceptional items (Note 8);

(c)     Payroll and related benefits (Note 9);

(d)    Additional information on operating expenses by nature (Note 10);

(e)     Intangible assets (Note 15);

(f)     Trade receivable (Note 19);

(g)    Changes in equity (Note 21);

(h)    Interest-bearing loans and borrowings (Note 22);

(i)      Employee benefits (Note 23);

(j)      Trade payables (Note 25);

(k)    Operating leases (Note 28);

(l)      Contingencies (Note 30);

(m) Group Companies (Note 34);

(n)    Insurance (Note 35)

 

Management declares that all relevant information specific to the financial statements, and only them, are being evidenced and correspond to those used by Management in its business management.

 

 

 

10


 
 

 

3.     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

There were no significant changes in accounting policies and calculation methods used for the interim financial statements as of June 30, 2017 in relation to those presented in the financial statements for the year ended December 31, 2016.

 

(a)    Basis of preparation and measurement

 

The interim financial statements are presented in thousands of Brazilian Real (“R$”), unless otherwise indicated, rounded to the nearest thousand indicated . Depending on the applicable IFRS requirement, the measurement basis used in preparing the interim financial statements is historical cost, net realizable value, fair value or recoverable amount.

 

(b)    Recently issued IFRS

 

The reporting standards below were published and are mandatory for future annual reporting periods . There were no early adoption of standards and amendments to standards however the Company is in the evaluation phase of the revised standards and does not expect significant impacts.

 

IFRS 9 Financial Instruments

 

The IFRS 9, which will replace IAS 39, introduces a logical approach for the classification of financial assets, which is driven by cash flow characteristics and the business model in which an asset is held; defines a new expected-loss impairment model that will require more effective recognition; and introduces a substantially-reformed model for hedge accounting, with enhanced disclosures about risk management activity. The new hedge accounting model represents a significant overhaul that aligns the accounting treatment with risk management activities. IFRS 9 also reduces the volatility in profit or loss that was caused by changes in the credit risk of liabilities elected to be measured at fair value. IASB issued IFRS 9, which will be effective for annual periods beginning on or after January 1st, 2018. The early adoption is not permitted by the Brazilian Accounting Pronouncements Committee.

 

IFRS 15 Revenue from Contracts with Customers

 

IFRS 15 requires revenue recognition to depict the transfer of goods or services to customers in amounts that reflect the consideration (that is, payment) to which the Company expects to be entitled in exchange for those goods or services. The new standard will also result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively and improve guidance for multiple-element arrangements. IASB issued IFRS 15, which will be effective for annual periods beginning on or after January 1st, 2018. The early adoption is not permitted by the Brazilian Accounting Pronouncements Committee.

 

 

 

 

11


 
 

 

IFRS 16 – Leases

 

The IFRS 16, which supersedes IAS 17, replaces the existing lease accounting requirements and represents a significant change in the accounting introducing the standardization of accounting recognition for the lessee and will require the recognition of the right to use and a lease liability. IASB issued IFRS 16, which will be effective for annual periods beginning on or after January 1st, 2019, with earlier adoption.

4.     USE OF ESTIMATES AND JUDGMENTS

 

The preparation of interim financial statements in conformity with IFRS requires Management to make judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on past experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for decision making regarding the judgments about carrying amounts of assets and liabilities that are not readily evident from other sources. Actual results may differ from these estimates.

The estimates and assumptions are reviewed on a regular basis. Changes in accounting estimates may affect the period in which they are realized, or future periods.

Although each of its significant accounting policies reflects judgments, assessments or estimates, the Company believes that the following accounting practices reflect the most critical judgments, estimates and assumptions that are important to its business operations and the understanding of its results:

(i) predecessor basis of accounting;

(ii) business combinations;

(iii) impairment;

(iv) provisions;

(v) share-based payments;

(vi) employee benefits;

(vii) current and deferred tax;

(viii) joint arrangements; e

(ix) measurement of financial instruments, including derivatives.

 

The fair values of acquired identifiable intangibles are based on an assessment of future cash flows. Impairment analyses of goodwill and indefinite-lived intangible assets are performed at least annually and whenever a triggering event occurs, in order to determine whether the carrying value exceeds the recoverable amount.

 

The company uses its judgment to select a variety of methods including the discounted cash flow method and option valuation models and makes assumptions about the fair value of financial instruments that are mainly based on market conditions existing at each balance sheet date.

 

 

 

12


 
 

 

Actuarial assumptions are established to anticipate future events and are used in calculating pension and other long-term employee benefit expense and liability. These factors include assumptions with respect to interest rates, rates of increase in health care costs, rates of future compensation increases, turnover rates, and life expectancy.

 

The company is subject to income tax in numerous jurisdictions. Significant judgment is required in determining the worldwide provision for income tax. There are some transactions and calculations for which the ultimate tax determination is uncertain. Some subsidiaries within the Company are involved in tax audits usually in relation to prior years. These audits are ongoing in various jurisdictions at the balance sheet date and, by their nature, these can take considerable time until its conclusion.

 

5.         CASH AND CASH EQUIVALENTS

 

 

06/30/2017

12/31/2016

     

Cash

104,011

381,928

Current bank accounts

3,020,992

3,467,339

Short term bank deposits (i)

5,632,339

4,027,582

Cash and cash equivalents

8,757,342

7,876,849

     

Bank overdrafts

(27,061)

-

Cash and cash equivalents less bank overdraft

8,730,281

7,876,849

 

(i) The balance refers mostly to Bank Deposit Certificates - CDB, high liquidity, which are readily convertible into known amounts of cash and which are subject to an insignificant risk of change in value.

 

6.         INVESTMENTS SECURITIES

 

 

06/30/2017

12/31/2016

     

Financial asset at fair value through profit or loss-held for trading

8,770

282,771

Current investments securities

8,770

282,771

     

Debt held-to-maturity

94,475

104,340

Non-current investments securities

94,475

104,340

     

Total

103,245

387,111

 

 

7.         INVENTORIES

 

 

06/30/2017

12/31/2016

     

Finished goods

1,843,492

1,445,462

Work in progress

357,232

328,453

Raw material

1,821,803

1,962,731

Consumables

72,935

50,026

Spare parts and other

461,767

447,167

Prepayments

218,094

234,473

Impairment losses

(111,372)

(121,260)

 

4,663,951

4,347,052

 

 

13


 
 

 

 

Write-offs/losses on inventories recognized in the income statement amounted to R$27,773 in the period ended in June 30, 2017 (R$ 31,730 in the period ended in June 30, 2016).

 

8.         DEFERRED INCOME TAX AND SOCIAL CONTRIBUTION

 

Deferred taxes for income tax and social contribution taxes are calculated on tax losses, the negative tax basis of social contributions and the temporary differences between the tax bases and the carrying amount in the interim financial statement of assets and liabilities. The rates of these taxes in Brazil, currently set for the determination of deferred taxes, are 25% for income tax and 9% for social contribution. For the other regions, with operational activity, applied rates, are as follow:

 

Central America and the Caribbean

from 23% to 31%

Latin America

from 14% to 35%

Canada

26%

 

Deferred tax assets are recognized to the extent that it is probable that future taxable profit will be available to be used to offset temporary differences / loss carry forwards based on projections of future results prepared and based on internal assumptions and future economic scenarios which may therefore change.

 

The amount of deferred income tax and social contribution by type of temporary difference is detailed as follows:

 

 

06/30/2017

 

12/31/2016

 

Assets

Liabilities

Net

 

Assets

Liabilities

Net

Investment securities

9,538

-

9,538

 

9,030

-

9,030

Intangible assets

-

(728,189)

(728,189)

 

649

(733,894)

(733,245)

Employee benefits

499,376

-

499,376

 

467,582

-

467,582

Trade payables - exchange rate

1,460,675

(411,107)

1,049,568

 

977,442

(531,285)

446,157

Trade receivable

45,175

-

45,175

 

42,724

-

42,724

Derivatives

87,399

(13,969)

73,430

 

71,134

(110,735)

(39,601)

Interest-bearing loans and borrowings

-

-

-

 

-

(1,372)

(1,372)

Inventories

176,120

(30,376)

145,744

 

267,430

(13,778)

253,652

Property, plant and equipment

-

(839,122)

(839,122)

 

-

(905,676)

(905,676)

Withholding tax over undistributed profits

-

(710,221)

(710,221)

 

-

(684,774)

(684,774)

Investments in associates

-

(421,590)

(421,590)

 

-

(421,590)

(421,590)

Interest on shareholders’ equity

653,383

-

653,383

 

-

-

-

Loss carryforwards

987,266

-

987,266

 

1,139,818

-

1,139,818

Provisions

404,495

(40,185)

364,310

 

448,879

(44,738)

404,141

Complement of income tax of foreign subsidiaries due in Brazil

-

(15,017)

(15,017)

 

-

-

-

Other items

-

(131,416)

(131,416)

 

(15,132)

(23,294)

(38,426)

Gross deferred tax assets / (liabilities)

4,323,427

(3,341,192)

982,235

 

3,409,556

(3,471,136)

(61,580)

Netting by taxable entity

(1,076,730)

1,076,730

-

 

(1,141,414)

1,141,414

-

Net deferred tax assets / (liabilities)

3,246,697

(2,264,462)

982,235

 

2,268,142

(2,329,722)

(61,580)

 

The Company only offsets the balances of deferred income tax and social contribution assets against liabilities when they are within the same entity and are expected to be realized in the same period.

 

 

14


 
 

 

Tax losses and negative bases of social contribution and temporary deductible differences in Brazil, on which the deferred income tax and social contribution were calculated, have no expiry date.

 

At June 30, 2017 the assets and liabilities deferred taxes related to combined tax losses has an expected utilization/settlement by temporary differences as follows:

 

 

06/30/2017

Deferred taxes not related to tax losses

to be realized until 12 months

to be realized after 12 months

Total

       

Investment securities

-

9,538

9,538

Intangible assets

-

(728,189)

(728,189)

Employee benefits

38,632

460,744

499,376

Trade payables - exchange rate

1,460,675

(411,107)

1,049,568

Trade receivable

41,939

3,236

45,175

Derivatives

73,430

-

73,430

Inventories

145,744

-

145,744

Property, plant and equipment

(69,078)

(770,044)

(839,122)

Withholding tax over undistributed profits

-

(710,221)

(710,221)

Investments in associates

-

(421,590)

(421,590)

Interest on shareholders’ equity

653,383

-

653,383

Complement of income tax of foreign subsidiaries due in Brazil

(15,017)

-

(15,017)

Provisions

31,676

332,634

364,310

Other items

-

(131,416)

(131,416)

 

2,361,384

(2,366,415)

(5,031)

 

Deferred tax related to tax losses

06/30/2017

2017

271,104

2018

249,985

2019

193,336

2020

35,089

Apart from 2021 (i)

237,752

 

987,266

(i) There is no expected realization that exceed the period of 10 years.

 

As at June 30, 2017, deferred tax assets in the amount of R$600,474 (R$455,616 in December 31, 2016) related to tax losses and temporary differences of subsidiaries abroad were not recorded as the realization is not probable.

 

Major part of the fiscal losses amount do not have carryforward limit for utilization and the tax losses carried forward in relation to them are equivalent to R$2,346,313 in June 30, 2017 (R$2,285,196 in December 31, 2016).

 

The net change in deferred income tax and social contribution is detailed as follows:

 

At December 31, 2016

(61,580)

Remeasurement of postemployment benefits

(22)

Investment hedge - put option of a subsidiary interest

(4,149)

Cash flow hedge - gains/(losses)

(152,625)

Gains/(losses) on translation of other foreign operations

221,790

Recognized in other comprehensive income

64,994

Recognized in income statement

700,083

Changes directly in balance sheet

278,738

At June 30, 2017

982,235

 

 

15


 
 

 

9.         PROPERTY, PLANT AND EQUIPMENT

 

 

06/30/2017

 

12/31/2016

 

Land and buildings

Plant and equipment

Fixtures and fittings

Under construction

Total

 

Total

Acquisition cost

             

Balance at end of previous year

8,330,123

22,764,314

4,584,187

1,740,739

37,419,363

 

36,685,586

Effect of movements in foreign exchange

31,769

151,836

29,405

8,637

221,647

 

(2,652,740)

Acquisitions through business combinations

-

-

-

-

-

 

700,372

Acquisitions through stock exchange

-

-

-

-

-

 

433,849

Disposals through stock exchange

-

-

-

-

-

 

(571,349)

Acquisitions

2,111

278,493

72,287

873,188

1,226,079

 

4,009,345

Disposals

(4,081)

(198,432)

(42,270)

(41)

(244,824)

 

(1,012,663)

Transfer to other asset categories

229,129

683,642

282,195

(1,366,680)

(171,714)

 

(173,037)

Others

79,725

(112,182)

-

-

(32,457)

 

-

Balance at end

8,668,776

23,567,671

4,925,804

1,255,843

38,418,094

 

37,419,363

               

Depreciation and Impairment

             

Balance at end of previous year

(2,278,115)

(13,075,250)

(2,912,162)

-

(18,265,527)

 

(17,545,499)

Foreign exchange effects

(11,293)

(119,612)

(24,348)

-

(155,253)

 

1,137,065

Disposals through stock exchange

-

-

-

-

-

 

345,919

Depreciation

(145,681)

(1,067,837)

(330,047)

-

(1,543,565)

 

(3,083,821)

Impairment losses

-

(49,993)

-

-

(49,993)

 

(120,905)

Disposals

664

185,601

35,382

-

221,647

 

928,903

Transfer to other asset categories

(2,531)

7,672

3,106

-

8,247

 

61,451

Others

-

4,423

-

-

4,423

 

11,360

Balance at end

(2,436,956)

(14,114,996)

(3,228,069)

-

(19,780,021)

 

(18,265,527)

Carrying amount:

             

December 31, 2016

6,052,008

9,689,064

1,672,025

1,740,739

19,153,836

 

19,153,836

June 30, 2017

6,231,820

9,452,675

1,697,735

1,255,843

18,638,073

   

 

Leases, capitalizes interests and fixed assets provided as security are not material.

 

10.     GOODWILL

 

 

06/30/2017

12/31/2016

     

Balance at end of previous year

30,511,200

30,953,066

Effect of movements in foreign exchange

389,468

(2,388,878)

Acquisitions and disposals through business combinations (i)

-

1,947,012

Others (ii)

195,663

-

Balance at the end of year

31,096,331

30,511,200

 

(i) It refers mainly  to the acquisition of Mark Anthony and Cerveceria Nacional in the transaction of stock exchanges.

 

(ii) It refers to the change in provisional allocations of assets acquired and liabilities assumed in the 2016 acquisitions.

 

 

 

16


 
 

 

The carrying amount of goodwill was allocated to the different cash-generating units as follows :

 

 

Functional currency

06/30/2017

12/31/2016

LAN:

     

Brazil

BRL

17,468,813

17,424,616

Goodwill

 

102,711,446

102,667,249

Non-controlling transactions (i)

 

(85,242,633)

(85,242,633)

Dominican Republic

DOP

3,216,922

3,224,896

Cuba (ii)

USD

3,123

3,634

Panama

PAB

1,143,298

1,060,063

       

LAS:

     

Argentina

ARS

502,027

517,934

Bolivia

BOB

1,170,181

1,152,815

Chile

CLP

43,605

42,722

Paraguay

PYG

793,532

753,724

Uruguay

UYU

172,587

165,767

       

NA:

     

Canada

CAD

6,582,243

6,165,029

   

31,096,331

30,511,200

 

(i) It refers to the stock exchange operation occurred in 2013 in result of the adoption of the predecessor basis of accounting.

 

(ii) The functional currency of Cuba, the Cuban convertible peso (CUC), has fixed parity with the dollar (USD) at balance sheet date.

 

 

11.     INTEREST-BEARING LOANS AND BORROWINGS

 

 

06/30/2017

12/31/2016

     

Secured bank loans

2,747,882

1,381,412

Unsecured bank loans

495,910

1,910,139

Debentures and unsecured bond issues

299,998

296,352

Other unsecured loans

39,026

33,479

Financial leasing

8,024

9,222

Current liabilities

3,590,840

3,630,604

     

Secured bank loans

581,278

665,786

Unsecured bank loans

511,712

609,848

Debentures and unsecured bond issues

101,771

100,803

Other unsecured loans

101,877

356,236

Financial leasing

30,158

33,033

Non-current liabilities

1,326,796

1,765,706

 

Ambev, through its subsidiary in Canadá, renegotiated one of its loans of R$669,904, maturing on September, 2017 .

 

Additional information regarding the exposure of the Company to the risks of interest rate and foreign currency are disclosed on Note 21 – Financial instruments and risks .

 

 

 

17


 
 

 

Contract clauses (covenants)

In the period ended June 30, 2017, the Company's loans had equal rights to payment without subordination clauses. Except for the credit lines due to FINAME contracted by the Company with Banco Nacional de Desenvolvimento Econômico e Social – BNDES (“BNDES”), where collateral is provided on assets acquired with the credit granted, the other loans and financing contracted by the Company provide for personal guarantees, or are unsecured. Most of the financial contracts provide for restrictive clauses (covenants), such as: financial covenants, including restrictions on new indebtedness; proof of company’s existence; maintenance, in use or in good conditions for the business, of the Company’s assets; restrictions on acquisitions, mergers, sale or disposal of its assets; disclosure of financial statements and balance sheets; and (prohibition related to new real guarantees for loans contracted, except if (i) expressly authorized under the loan agreement in question; or (ii) new loans contracted with financial institutions linked to the Brazilian government – including the BNDES – or foreign governments, whether multilateral financial institutions (e.g., World Bank) or located in jurisdictions in which the Company operates.

On June 30, 2017, the Company was in compliance with all of its contractual obligations relating to its loans and financings.

 

12.     PROVISIONS

(a) Provision changes

 

Balance as of
December 31, 2016

Effect of changes in
foreign exchange rates

Additions

Provisions used
and reversed

Balance as of
June 30, 2017

           

Restructuring

7,451

409

-

(21)

7,839

           

Provision for contingencies

         

Taxes on sales

247,185

(8)

30,360

(27,861)

249,676

Income tax

323,458

2,918

135,203

(274)

461,305

Labor

165,701

(198)

68,940

(77,635)

156,808

Civil

43,961

70

19,872

(34,740)

29,163

Others

146,250

(1,253)

28,094

(19,669)

153,422

Total of provision for contingencies

926,555

1,529

282,469

(160,179)

1,050,374

           

Total of provisions

934,006

1,938

282,469

(160,200)

1,058,213

 

 

18


 
 

 

(b)    Disbursement expectative

 

 

Balance as of
June 30, 2017

1 year or less

1-2 years

2-5 years

Over 5 years

           

Restructuring

7,839

7,055

-

784

-

           

Provision for contingencies

         

Taxes on sales

249,676

25,716

200,842

5,596

17,522

Income tax

461,305

33,598

349,044

78,663

-

Labor

156,808

77,257

41,214

30,007

8,330

Civil

29,163

17,112

9,516

1,540

995

Others

153,422

7,987

37,655

104,319

3,461

Total of provision for contingencies

1,050,374

161,670

638,271

220,125

30,308

           

Total of provisions

1,058,213

168,725

638,271

220,909

30,308

 

 

Balance as of
December 31, 2016

1 year or less

1-2 years

2-5 years

Over 5 years

           

Restructuring

7,451

6,705

746

-

-

           

Provision for contingencies

         

Taxes on sales

247,185

25,716

198,608

5,534

17,327

Income tax

323,458

33,592

236,556

53,310

-

Labor

165,701

77,357

45,770

33,324

9,250

Civil

43,961

17,325

21,033

3,403

2,200

Others

146,250

7,941

35,809

99,208

3,292

Total of provision for contingencies

926,555

161,931

537,776

194,779

32,069

           

Total of provisions

934,006

168,636

538,522

194,779

32,069

 

The expected settlement of provisions was based on management’s best estimate at the balance sheet date.

Main lawsuits with probable likelihood of loss:

(a) Income and Sales taxes

 

In Brazil, the Company and its subsidiaries are involved in several administrative and judicial proceedings related to Income tax, ICMS, IPI, PIS and COFINS taxes. Such proceedings include, among others, tax offsets, credits and judicial injunctions exempting tax payment.

 

(b) Labor

The Company and its subsidiaries are involved in labor proceedings with former employees or former employees of service providers. The main issues involve overtime and related effects and respective charges.

 

 

19


 
 

 

(c) Civil

The Company is involved in civel lawsuits considered with probable likelihood of loss. The most relevant portion of these lawsuits refers to former distributors, mainly in Brazil, which are mostly claiming damages resulting from the termination of their contracts.

 

The processes with possible probabilities are disclosed in Note 23 - Contingencies .

 

13.     CHANGES IN EQUITY

 

(a) Capital stock

 

 

 

06/30/2017

 

 

06/30/2016

 

Thousands of
common shares

Thousands
of Real

 

Thousands of
common shares

Thousands
of Real

Beginning balance as per statutory books

15,717,615

57,614,140

 

15,717,615

57,614,140

Share issued

-

-

 

-

-

 

15,717,615

57,614,140

 

15,717,615

57,614,140

 

(b)    Capital reserves

 

 

Capital Reserves

 

 

Treasury shares

Share Premium

Others capital
reserves

Share-based Payments

Total

           

At January 1, 2017

(908,676)

53,662,811

700,898

1,074,747

54,529,780

Purchase of shares and result on treasury shares

18,413

-

-

-

18,413

Share-based payments

-

-

-

35,683

35,683

At June 30, 2017

(890,263)

53,662,811

700,898

1,110,430

54,583,876

 

 

Capital Reserves

 

 

Treasury shares

Share Premium

Others capital
reserves

Share-based Payments

Total

           

At January 1, 2016

(1,003,508)

53,662,811

700,898

1,013,250

54,373,451

Purchase of shares and result on treasury shares

88,335

-

-

-

88,335

Share-based payments

-

-

-

(11,850)

(11,850)

At June 30, 2016

(915,173)

53,662,811

700,898

1,001,400

54,449,936

 

 

(b.1) Treasury shares

The treasury shares comprise own issued shares reacquired by the Company and the result on treasury shares that refers to gains and losses related to share-based payments transactions and others.

 

 

 

20


 
 

 

Follows the changes of treasury shares:

 

 

Purchase /realization shares

 

Result on Treasure shares

 

Total Treasure shares

 

Thousands shares

 

Thousands
Brazilian Real

 

Thousands shares

 

Thousands
Brazilian Real

       

At January 1, 2017

16,512

 

(312,670)

 

(596,006)

 

(908,676)

Changes during the year

(6,073)

 

119,585

 

(101,172)

 

18,413

At June 30, 2017

10,439

 

(193,085)

 

(697,178)

 

(890,263)

 

 

Purchase /realization shares

 

Result on Treasure Shares

 

Total Treasure Shares

 

Thousands shares

 

Thousands
Brazilian Real

 

Thousands shares

 

Thousands
Brazilian Real

       

At January 1, 2016

32,521

 

(617,407)

 

(386,101)

 

(1,003,508)

Changes during the year

(13,395)

 

254,898

 

(166,563)

 

88,335

At June 30, 2016

19,126

 

(362,509)

 

(552,664)

 

(915,173)

 

(b.2) Share premium

 

The share premium refers to the difference between subscription price that the shareholders paid for the shares and theirs nominal value. Since this is a capital reserve, it can only be used to increase capital, offset losses, redemptions, reimbursement or repurchase shares.

(b.3) Share-based payment

There are different share-based payment programs and stock option plans which allow the senior management from Ambev economic group to receive or acquire shares of the Company.

The share-based payment reserve recorded a charge of R$86,382 at June 30, 2017 ( R$85,549 at June 30, 2016 ) (Note 20 – Share-based payments ).

(c)     Net income reserves

 

 

Net income reserves

 

Investment reserve

Statutory reserve

Fiscal incentive

Interest on capital and
dividends proposed

Total

At January 1, 2017

3,859,995

4,456

5,835,797

-

9,700,248

           

At June 30, 2017

3,859,995

4,456

5,835,797

-

9,700,248

 

 

Net income reserves

 

Investment reserve

Statutory reserve

Fiscal incentive

Interest on capital and
dividends proposed

Total

 

 

 

 

 

 

At January 1, 2016

2,141,424

4,456

4,016,272

2,039,171

8,201,323

Interest on shareholders’ equity

-

-

-

(2,039,171)

(2,039,171)

At June 30, 2016

2,141,424

4,456

4,016,272

-

6,162,152

 

 

 

21


 
 

 

(c.1) Investments reserve

From net income after deductions applicable, will be aimed no more than 60% (sixty per cent) to investment reserve to support future investments.

(c.2) Statutory reserve

From net income, 5% will be applied before any other allocation, to the statutory reserve, which cannot exceed 20% of capital stock. The Company is not required to supplement the statutory reserve in the year when the balance of this reserve, plus the amount of capital reserves, exceeds 30% of the capital stock.

(c.3) Tax incentives

The Company has tax incentives framed in certain state and federal industrial development programs in the form of financing, deferred payment of taxes or partial reductions of the amount due. These state programs aim to promote the expansion of employment generation, regional decentralization, complement and diversify the industrial base of the States. In these states, the grace periods, enjoyment and reductions are permitted under the tax law.

The portion of income for the period related to tax incentives, which will be allocated to the profit reserve at the end of the fiscal year on December 31, 2017 and therefore not being used as a basis for dividend distribution, is composed of:

 

06/30/2017

06/30/2016

ICMS (Brazilian State value added)

849,444

724,082

Income tax

79,022

101,451

 

928,466

825,533

 

(c.4) Interest on shareholders’ equity / Dividends

Brazilian companies are permitted to distribute interest attributed to shareholders’ equity calculated based on the long-term interest rate (TJLP), such interest being tax-deductible, in accordance with the applicable law and, when distributed, may be considered part of the minimum mandatory dividends.

As determined by its By-laws, the Company is required to distribute to its shareholders, as a minimum mandatory dividend in respect of each fiscal year ending on December 31,an amount not less than 40% of its net income determined under Brazilian law, as adjusted in accordance with applicable law, unless payment of such amount would be incompatible with Ambev’s financial situation. The minimum mandatory dividend includes amounts paid as interest on shareholders’ equity.

 

 

22


 
 

 

Events during six-month period ended June 30, 2017:

 

Event

Approval

Type

Date of payment

Year

Type of share

Amount per share

Total amount

Board of Directors Meeting

05/17/2017

Dividends

07/17/2016

2017

ON

0.1600

2,513,077

             

2,513,077

 

Events during six-month period ended June 30, 2016:

 

Event

Approval

Type

Date of payment

Year

Type of share

Amount per share

Total amount

Board of Directors Meeting

01/15/2016

Interest on shareholders’ equity

02/29/2016

2015

ON

0.1300

2,039,171

Board of Directors Meeting

06/24/2016

Dividends

07/29/2016

2016

ON

0.1300

2,040,800

             

4,079,971

 

 

 

 

23


 
 

 

(d) Carrying value adjustments

 

 

Carrying value adjustments

 

 

Translation
reserves

Cash flow
hedge

Actuarial gains/
(losses)

Put option
granted on
subsidiary

Gains/(losses) of non-controlling interest´s share

Business combination

Accounting adjustments for transactions between shareholders

Total

At January 1, 2017

(289,483)

(144,568)

(1,262,170)

(2,390,843)

2,150,643

156,091

(75,238,790)

(77,019,120)

Comprehensive income:

               

Gains/(losses) on translation of foreign operations

732,889

-

-

-

-

-

-

732,889

Cash flow hedges

-

301,096

-

-

-

-

-

301,096

Actuarial gains/(losses)

-

-

159,816

-

-

-

-

159,816

Total Comprehensive income

732,889

301,096

159,816

-

-

-

-

1,193,801

Gains/(losses) of controlling interest´s share

-

-

-

-

(3,081)

-

-

(3,081)

At June 30, 2017

443,406

156,528

(1,102,354)

(2,390,843)

2,147,562

156,091

(75,238,790)

(75,828,400)

 

 

 

 

 

Carrying value adjustments

 

 

Translation
reserves

Cash flow
hedge

Actuarial gains/
(losses)

Put option
granted on

subsidiary

Gains/(losses) of non-controlling interest´s share

Business combination

Accounting adjustments for transactions between shareholders

Total

At January 1, 2016

3,472,291

932,109

(1,131,499)

(2,246,679)

2,123,565

156,091

(75,162,909)

(71,857,031)

Comprehensive income:

               

Gains/(losses) on translation of foreign operations

(3,486,740)

-

-

-

-

-

-

(3,486,740)

Cash flow hedges

-

(1,202,253)

-

-

-

-

-

(1,202,253)

Actuarial gains / (losses)

-

-

1,152

-

-

-

-

1,152

Total Comprehensive income

(3,486,740)

(1,202,253)

1,152

-

-

-

-

(4,687,841)

Put option granted on subsidiary

-

-

-

(144,079)

-

-

-

(144,079)

Gains / (losses) of controlling interest´s share

-

-

-

-

(9,175)

-

-

(9,175)

At June 30, 2016

(14,449)

(270,144)

(1,130,347)

(2,390,758)

2,114,390

156,091

(75,162,909)

(76,698,126)

 

 

 

 

24


 
 

 

(d.1) Translation reserves

 

The translation reserves comprise all foreign currency exchange differences arising from the translation of the interim financial statements with functional currency different from the Real.

The translation reserves also comprise the portion of the gain or loss on the foreign currency liabilities and on the derivative financial instruments determined to be effective net investment hedges in conformity with IAS 39.

 

(d.2) Cash flow hedge reserves

 

The hedging reserves comprise the effective portion of the cumulative net change in the fair value of cash flow hedges to the extent the hedged risk has not yet impacted profit or loss (For additional information, see Note 21 – Financial instruments and risks) .

 

(d.3) Actuarial gains and losses

The actuarial gains and losses include expectations with regards to the future pension plans obligations. Consequently, the results of actuarial gains and losses are recognized on timely basis considering best estimate obtained by Management. Accordingly, the Company recognizes on monthly basis the results of these estimated actuarial gains and losses according to the expectations presented based on an independent actuarial report.

The actuarial gain of R$158,509 arising from the surplus reverted to the Sponsor, originating from Ambev Private Pension Institute of the defined benefits plan was fully recorded under the heading of actuarial gains and losses.

(d.4) O ptions granted on subsidiary

As part of the shareholders agreement between the Ambev and ELJ, an option to sell (“put”) and to purchase (“call”) was issued, which may result in an acquisition by Ambev of the remaining shares of CND, for a value based on EBITDA from operations, the “put” exercisable annually until 2019 and the “call” from 2019. On June 30, 2017 the put option held by ELJ is valued at R$5,146,155 (R$4,879,459 on December 31, 2016) and the liability categorized as “Level 3”, as the Note 21 (b) and in accordance with the IFRS 3. No value has been assigned to the call option held by the Company. The fair value of this consideration deferred was calculated by using standard valuation techniques (present value of the principal amount and future interest rates, discounted by the market rate). The criteria used are based on market information and from reliable sources and the fair value is revaluated on an annual basis.

 

As part of the agreement to acquire the remaining shares of Sucos do Bem, the Company has a put option determined by gross revenue of its products and exercisable from 2019. On June 30, 2017 the option is valued at R$130,333 (R$127,718 on December 31, 2016).

 

 

25


 
 

 

As part of the acquisition agreement of all shares of the company Tropical Juice, the Company has put option exercisable from 2018. On June 30, 2017 the option is valued at R$23,380 (R$23,380 on December 31, 2016).

 

The reconciliation of changes in these options is presented in Note 21 – Financial instruments and risks .

 

(d.5) Accounting for acquisition of non-controlling interests

In transactions with non-controlling interests of the same business, even when performed at arm's length terms, that present valid economic grounds and reflect normal market conditions, will be consolidated by the applicable accounting standards as occurred within the same accounting entity.

As determined by IFRS 10, any difference between the amount paid (fair value) for the acquisition of non-controlling interests and are related to carrying amount of such non-controlling interest shall be recognized directly in controlling shareholders’ equity. The acquisition of non-controlling interest related to Old Ambev, the above mentioned adjustment was recognized in the Carrying value adjustments when applicable.

 

 

26


 
 

 

14.     SEGMENT REPORTING

 

Segment information is presented in thousands of Brazilian Reais (R$).

(a)       Reportable segments – six-month periods ended in:

 

Latin America - north (i)

Latin America - south (ii)

Canada

Consolidated

 

06/30/2017

06/30/2016

06/30/2017

06/30/2016

06/30/2017

06/30/2016

06/30/2017

06/30/2016

                 

Net sales

13,805,363

13,809,447

4,850,036

4,787,291

2,854,359

3,345,564

21,509,758

21,942,302

Cost of sales

(5,759,706)

(4,989,291)

(1,921,131)

(1,772,338)

(890,493)

(1,093,292)

(8,571,330)

(7,854,921)

Gross profit

8,045,657

8,820,156

2,928,905

3,014,953

1,963,866

2,252,272

12,938,428

14,087,381

Distribution expenses

(1,986,569)

(1,897,108)

(471,922)

(473,741)

(520,221)

(602,094)

(2,978,712)

(2,972,943)

Sales and marketing expenses

(1,769,480)

(1,826,546)

(575,804)

(648,137)

(451,858)

(554,737)

(2,797,142)

(3,029,420)

Administrative expenses

(735,913)

(734,045)

(200,709)

(200,097)

(139,817)

(153,047)

(1,076,439)

(1,087,189)

Other operating income/(expenses)

502,656

779,064

8,315

(43,385)

2,425

(12,212)

513,396

723,467

Exceptional items

(29,808)

(11,958)

(30,971)

(8,508)

-

(7,999)

(60,779)

(28,465)

Income from operations (EBIT)

4,026,543

5,129,563

1,657,814

1,641,085

854,395

922,183

6,538,752

7,692,831

Net finance cost

(1,135,747)

(2,058,172)

(402,484)

(245,268)

(33,186)

232,252

(1,571,417)

(2,071,188)

Share of result of associates

5,552

6,879

-

-

749

958

6,301

7,837

Income before income tax

2,896,348

3,078,270

1,255,330

1,395,817

821,958

1,155,393

4,973,636

5,629,480

Income tax expense

322,938

49,304

(583,320)

(366,243)

(298,590)

(246,027)

(558,972)

(562,966)

Net income

3,219,286

3,127,574

672,010

1,029,574

523,368

909,366

4,414,664

5,066,514

                 

Normalized EBITDA (iii)

5,351,120

6,430,953

2,010,025

2,000,636

938,351

1,037,378

8,299,496

9,468,967

Exceptional items

(29,808)

(11,958)

(30,971)

(8,508)

-

(7,999)

(60,779)

(28,465)

 

(1,294,769)

(1,289,432)

(321,240)

(351,043)

(83,956)

(107,196)

(1,699,965)

(1,747,671)

Net finance costs

(1,135,747)

(2,058,172)

(402,484)

(245,268)

(33,186)

232,252

(1,571,417)

(2,071,188)

Share of results of associates

5,552

6,879

-

-

749

958

6,301

7,837

Income tax expense

322,938

49,304

(583,320)

(366,243)

(298,590)

(246,027)

(558,972)

(562,966)

Net income

3,219,286

3,127,574

672,010

1,029,574

523,368

909,366

4,414,664

5,066,514

                 

Normalized EBITDA margin in %

38.8%

46.6%

41.4%

41.8%

32.9%

31.0%

38.6%

43.2%

                 

Acquisition of property, plant and equipment

795,615

1,081,683

347,864

592,910

106,867

137,548

1,250,346

1,812,141

                 
 

06/30/2017

12/31/2016

06/30/2017

12/31/2016

06/30/2017

12/31/2016

06/30/2017

12/31/2016

Segment assets

48,543,113

50,935,027

11,027,825

11,149,019

10,276,252

9,245,718

69,847,190

71,329,764

Intersegment elimination

           

(3,173,763)

(3,968,045)

Non-segmented assets

           

17,450,584

16,479,699

Total assets

           

84,124,011

83,841,418

                 

Segment liabilities

20,614,049

22,958,871

4,770,131

5,576,413

3,741,639

3,275,676

29,125,819

31,810,960

Intersegment elimination

           

(3,174,976)

(3,968,045)

Non-segmented liabilities

           

58,173,168

55,998,503

Total liabilities

           

84,124,011

83,841,418

 

(i) Latin America – North: includes operations in Brazil, Luxembourg  and CAC (El Salvador, Guatemala, Nicaragua, Dominican Republic, Saint Vincent, Dominica,  Antigua, Cuba,  Barbados and Panama).

 

(ii) Latin America – South: includes operations in Argentina, Bolivia, Chile, Paraguay and Uruguay.

 

(iii) Normalized  EBITDA is calculated excluding of the net income the following effects: (i) Income tax expense , (ii) Share of results of associates , (iii) Net finance result , (iv) Exceptional items, and (v) Depreciation, amortization and impairment of property, plant and equipment.

 

 

27


 
 

 

(b)      Reportable segments – three-month periods ended in:

 

Latin America - north (i)

Latin America - south (ii)

Canada

Consolidated

 

06/30/2017

06/30/2016

06/30/2017

06/30/2016

06/30/2017

06/30/2016

06/30/2017

06/30/2016

                 

Net sales

6,453,297

6,533,784

2,086,047

1,813,439

1,728,609

2,029,981

10,267,953

10,377,204

Cost of sales

(2,631,289)

(2,504,444)

(861,224)

(728,083)

(555,676)

(662,078)

(4,048,189)

(3,894,605)

Gross profit

3,822,008

4,029,340

1,224,823

1,085,356

1,172,933

1,367,903

6,219,764

6,482,599

Distribution expenses

(954,515)

(925,891)

(213,650)

(192,911)

(299,103)

(339,010)

(1,467,268)

(1,457,812)

Sales and marketing expenses

(852,130)

(887,281)

(273,171)

(291,537)

(258,055)

(302,725)

(1,383,356)

(1,481,543)

Administrative expenses

(359,263)

(385,382)

(103,278)

(97,984)

(58,239)

(70,185)

(520,780)

(553,551)

Other operating income/(expenses)

214,423

352,519

6,877

(15,655)

1,270

(5,732)

222,570

331,132

Exceptional items

(13,649)

(5,719)

(18,436)

(8,508)

-

(7,999)

(32,085)

(22,226)

Income from operations (EBIT)

1,856,874

2,177,586

623,165

478,761

558,806

642,252

3,038,845

3,298,599

Net finance cost

(441,685)

(976,623)

(246,330)

(28,312)

(10,807)

105,052

(698,822)

(899,883)

Share of result of associates

4,858

(136)

-

-

411

524

5,269

388

Income before income tax

1,420,047

1,200,827

376,835

450,449

548,410

747,828

2,345,292

2,399,104

Income tax expense

261,810

(10,552)

(286,287)

(15,319)

(195,982)

(200,712)

(220,459)

(226,583)

Net income

1,681,857

1,190,275

90,548

435,130

352,428

547,116

2,124,833

2,172,521

                 

Normalized EBITDA (iii)

2,519,106

2,830,880

806,657

664,921

617,562

708,821

3,943,325

4,204,622

Exceptional items

(13,649)

(5,719)

(18,436)

(8,508)

-

(7,999)

(32,085)

(22,226)

Depreciation, amortization and impairment excluding exceptional items

(648,583)

(647,575)

(165,056)

(177,652)

(58,756)

(58,570)

(872,395)

(883,797)

Net finance costs

(441,685)

(976,623)

(246,330)

(28,312)

(10,807)

105,052

(698,822)

(899,883)

Share of results of associates

4,858

(136)

-

-

411

524

5,269

388

Income tax expense

261,810

(10,552)

(286,287)

(15,319)

(195,982)

(200,712)

(220,459)

(226,583)

Net income

1,681,857

1,190,275

90,548

435,130

352,428

547,116

2,124,833

2,172,521

                 

Normalized EBITDA margin in %

39.0%

43.3%

38.7%

36.7%

35.7%

34.9%

38.4%

40.5%

 

(i) Latin America – North: includes operations in Brazil, Luxembourg  and CAC (El Salvador, Guatemala, Nicaragua, Dominican Republic, Saint Vincent, Dominica,  Antigua, Cuba,  Barbados and Panama).

 

(ii) Latin America – South: includes operations in Argentina, Bolivia, Chile, Paraguay and Uruguay.

 

(iii) Normalized  EBITDA is calculated excluding of the net income the following effects: (i) Income tax expense , (ii) Share of results of associates , (iii) Net finance result , (iv) Exceptional items, and (v) Depreciation, amortization and impairment of property, plant and equipment.

 

 

28


 
 

 

(c)       Additional information – by Business unit:

 

S ix-month period ended:

 

 Three-month period ended:

 

Latin America - north

 

Latin America - north

 

CAC

Brazil

Total

 

CAC

Brazil

Total

 

06/30/2017

06/30/2016

06/30/2017

06/30/2016

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

06/30/2017

06/30/2016

06/30/2017

06/30/2016

                           

Net sales

2,186,179

1,998,756

11,619,184

11,810,690

13,805,363

13,809,446

 

1,128,307

981,187

5,324,990

5,552,596

6,453,297

6,533,783

Cost of sales

(953,326)

(912,109)

(4,806,380)

(4,077,181)

(5,759,706)

(4,989,290)

 

(489,403)

(440,262)

(2,141,886)

(2,064,181)

(2,631,289)

(2,504,443)

Gross profit

1,232,853

1,086,647

6,812,804

7,733,509

8,045,657

8,820,156

 

638,904

540,925

3,183,104

3,488,415

3,822,008

4,029,340

Distribution expenses

(253,561)

(205,293)

(1,733,008)

(1,691,815)

(1,986,569)

(1,897,108)

 

(126,967)

(103,415)

(827,548)

(822,476)

(954,515)

(925,891)

Sales and marketing expenses

(241,451)

(229,279)

(1,528,029)

(1,597,267)

(1,769,480)

(1,826,546)

 

(112,323)

(106,898)

(739,807)

(780,383)

(852,130)

(887,281)

Administrative expenses

(120,935)

(97,402)

(614,978)

(636,642)

(735,913)

(734,044)

 

(60,542)

(54,259)

(298,721)

(331,122)

(359,263)

(385,381)

Other operating income/(expenses)

1,333

4,877

501,323

774,187

502,656

779,064

 

(6,740)

(1,776)

221,163

354,295

214,423

352,519

Exceptional items

(17,409)

-

(12,399)

(11,958)

(29,808)

(11,958)

 

(6,758)

-

(6,891)

(5,719)

(13,649)

(5,719)

Income from operations (EBIT)

600,830

559,550

3,425,713

4,570,014

4,026,543

5,129,564

 

325,574

274,577

1,531,300

1,903,010

1,856,874

2,177,587

Net finance cost

(56,479)

(14,979)

(1,079,268)

(2,043,193)

(1,135,747)

(2,058,172)

 

(6,388)

29,755

(435,297)

(1,006,378)

(441,685)

(976,623)

Share of result of associates

9,890

13,048

(4,338)

(6,169)

5,552

6,879

 

6,126

2,992

(1,268)

(3,128)

4,858

(136)

Income before income tax

554,241

557,619

2,342,107

2,520,652

2,896,348

3,078,271

 

325,312

307,324

1,094,735

893,504

1,420,047

1,200,828

Income tax expense

(155,111)

(167,186)

478,049

216,490

322,938

49,304

 

(84,274)

(88,490)

346,084

77,938

261,810

(10,552)

Net income

399,130

390,433

2,820,156

2,737,142

3,219,286

3,127,575

 

241,038

218,834

1,440,819

971,442

1,681,857

1,190,276

                           

Normalized EBITDA (i)

808,829

732,307

4,542,291

5,698,647

5,351,120

6,430,954

 

431,908

353,554

2,087,198

2,477,327

2,519,106

2,830,881

Exceptional items

(17,409)

-

(12,399)

(11,958)

(29,808)

(11,958)

 

(6,758)

-

(6,891)

(5,719)

(13,649)

(5,719)

Depreciation. amortization and impairment excluding exceptional items

(190,590)

(172,757)

(1,104,179)

(1,116,675)

(1,294,769)

(1,289,432)

 

(99,576)

(78,977)

(549,007)

(568,598)

(648,583)

(647,575)

Net finance costs

(56,479)

(14,979)

(1,079,268)

(2,043,193)

(1,135,747)

(2,058,172)

 

(6,388)

29,755

(435,297)

(1,006,378)

(441,685)

(976,623)

Share of results of associates

9,890

13,048

(4,338)

(6,169)

5,552

6,879

 

6,126

2,992

(1,268)

(3,128)

4,858

(136)

Income tax expense

(155,111)

(167,186)

478,049

216,490

322,938

49,304

 

(84,274)

(88,490)

346,084

77,938

261,810

(10,552)

Net income

399,130

390,433

2,820,156

2,737,142

3,219,286

3,127,575

 

241,038

218,834

1,440,819

971,442

1,681,857

1,190,276

                           

Normalized EBITDA margin in %

37.0%

36.6%

39.1%

48.2%

38.8%

46.6%

 

38.3%

36.0%

39.2%

44.6%

39.0%

43.3%

 

(i) Normalized EBITDA is calculated excluding of the net income the following effects: (i) Income tax expense , (ii) Share of results of associates , (iii) Net finance result , (iv) Exceptional items, and (v) Depreciation, amortization and impairment of property, plant and equipment.

 

 

29


 
 

 

 

  Six-month period ended:

 

Three-month period ended:

 

Brazil

 

Brazil

 

Beer

Soft drink and
Non-alcoholic and
non-carbonated

Total

 

Beer

Soft drink and
Non-alcoholic and
non-carbonated

Total

 

06/30/2017

06/30/2016

06/30/2017

06/30/2016

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

06/30/2017

06/30/2016

06/30/2017

06/30/2016

                           

Net sales

9,916,819

10,011,436

1,702,365

1,799,254

11,619,184

11,810,690

 

4,546,354

4,701,579

778,636

851,017

5,324,990

5,552,596

Cost of sales

(3,835,217)

(3,233,391)

(971,163)

(843,790)

(4,806,380)

(4,077,181)

 

(1,721,306)

(1,634,003)

(420,580)

(430,178)

(2,141,886)

(2,064,181)

Gross profit

6,081,602

6,778,045

731,202

955,464

6,812,804

7,733,509

 

2,825,048

3,067,576

358,056

420,839

3,183,104

3,488,415

Distribution expenses

(1,404,349)

(1,373,124)

(328,659)

(318,691)

(1,733,008)

(1,691,815)

 

(672,332)

(659,954)

(155,216)

(162,522)

(827,548)

(822,476)

Sales and marketing expenses

(1,437,394)

(1,481,805)

(90,635)

(115,462)

(1,528,029)

(1,597,267)

 

(697,722)

(748,869)

(42,085)

(31,514)

(739,807)

(780,383)

Administrative expenses

(530,183)

(575,246)

(84,795)

(61,396)

(614,978)

(636,642)

 

(257,532)

(285,391)

(41,189)

(45,731)

(298,721)

(331,122)

Other operating income/(expenses)

401,060

619,226

100,263

154,961

501,323

774,187

 

178,251

282,459

42,912

71,836

221,163

354,295

Exceptional items

(10,560)

(11,461)

(1,839)

(497)

(12,399)

(11,958)

 

(5,899)

(5,414)

(992)

(305)

(6,891)

(5,719)

Income from operations (EBIT)

3,100,176

3,955,635

325,537

614,379

3,425,713

4,570,014

 

1,369,814

1,650,407

161,486

252,603

1,531,300

1,903,010

Net finance cost

(1,079,268)

(2,043,193)

-

-

(1,079,268)

(2,043,193)

 

(435,297)

(1,006,378)

-

-

(435,297)

(1,006,378)

Share of result of associates

(4,338)

(6,169)

-

-

(4,338)

(6,169)

 

(1,268)

(3,128)

-

-

(1,268)

(3,128)

Income before income tax

2,016,570

1,906,273

325,537

614,379

2,342,107

2,520,652

 

933,249

640,901

161,486

252,603

1,094,735

893,504

Income tax expense

478,049

216,490

-

-

478,049

216,490

 

346,084

77,938

-

-

346,084

77,938

Net income

2,494,619

2,122,763

325,537

614,379

2,820,156

2,737,142

 

1,279,333

718,839

161,486

252,603

1,440,819

971,442

                           

Normalized EBITDA (i)

4,070,505

4,906,150

471,786

792,497

4,542,291

5,698,647

 

1,855,572

2,133,804

231,626

343,523

2,087,198

2,477,327

Exceptional items

(10,560)

(11,461)

(1,839)

(497)

(12,399)

(11,958)

 

(5,899)

(5,414)

(992)

(305)

(6,891)

(5,719)

Depreciation, amortization and impairment excluding exceptional items

(959,769)

(939,054)

(144,410)

(177,621)

(1,104,179)

(1,116,675)

 

(479,859)

(477,983)

(69,148)

(90,615)

(549,007)

(568,598)

Net finance costs

(1,079,268)

(2,043,193)

-

-

(1,079,268)

(2,043,193)

 

(435,297)

(1,006,378)

-

-

(435,297)

(1,006,378)

Share of results of associates

(4,338)

(6,169)

-

-

(4,338)

(6,169)

 

(1,268)

(3,128)

-

-

(1,268)

(3,128)

Income tax expense

478,049

216,490

-

-

478,049

216,490

 

346,084

77,938

-

-

346,084

77,938

Net income

2,494,619

2,122,763

325,537

614,379

2,820,156

2,737,142

 

1,279,333

718,839

161,486

252,603

1,440,819

971,442

                           

Normalized EBITDA margin in %

41.0%

49.0%

27.7%

44.0%

39.1%

48.2%

 

40.8%

45.4%

29.7%

40.4%

39.2%

44.6%

 

(i) Normalized EBITDA is calculated excluding of the net income the following effects: (i) Income tax expense , (ii) Share of results of associates , (iii) Net finance result , (iv) Exceptional items, and (v) Depreciation, amortization and impairment of  property, plant and equipment.

 

30


 
 

 

15.     NET SALES

 

The reconciliation between gross sales and net sales is as follows:

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Gross sales (i)

33,102,339

43,929,257

 

15,613,123

18,950,050

Excise duty

(7,520,818)

(8,578,492)

 

(3,542,766)

(4,105,527)

Discounts (i)

(4,071,763)

(13,408,463)

 

(1,802,404)

(4,467,319)

 

21,509,758

21,942,302

 

10,267,953

10,377,204

 

(i)     Variance resulting from the change in the billing method with direct effect on Gross sales and Discounts.

 

Services provided by distributors, such as the promotion of our brands and logistics services are considered as expense when separately identifiable.

 

16.     OTHER OPERATING INCOME / (EXPENSES)

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Government grants/NPV of long term fiscal incentives

427,531

673,165

 

205,634

317,846

(Additions)/Reversals to provisions

(27,701)

(28,857)

 

(17,150)

(6,616)

Gains/(losses) on disposal of property, plant and equipment and intangible assets

2,689

28,170

 

8,065

25,255

Other operating income/(expenses), net

110,877

50,989

 

26,021

(5,353)

 

513,396

723,467

 

222,570

331,132

 

Government grants are not recognized until there is reasonable assurance that the Company will meet related conditions and that the grants will be received. Government grants are systematically recognized in income during the periods in which the Company recognizes as expenses the related costs that the grants are intended to offset.

 

17.     EXCEPTIONAL ITEMS

 

The exceptional items included in the income statement are detailed below:

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Restructuring

(59,686)

(20,466)

 

(31,692)

(14,227)

Costs arising from business combinations

(1,093)

(7,999)

 

(393)

(7,999)

 

(60,779)

(28,465)

 

(32,085)

(22,226)

 

The Company opted to exclude these items when measuring segment-based performance, as per Note 14 – Segment reporting .

 

31


 
 

 

18.     FINANCE COST AND INCOME

 

(a)      Finance costs

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Interest expense

(792,505)

(721,750)

 

(389,662)

(358,671)

Capitalized borrowings

617

2,851

 

18

723

Net Interest on pension plans

(49,663)

(56,276)

 

(24,749)

(27,613)

Losses on hedging instruments

(391,890)

(997,270)

 

(143,279)

(474,695)

Interest on provision for contingencies

(120,741)

(265,245)

 

(48,051)

(47,138)

Exchange variation

(187,246)

(320,368)

 

(100,104)

(50,664)

Tax on financial transactions

(71,615)

(90,643)

 

(33,646)

(47,295)

Bank guarantee expenses

(43,830)

(45,675)

 

(22,562)

(21,974)

Other financial results

(161,077)

(35,072)

 

(59,657)

(8,664)

 

(1,817,950)

(2,529,448)

 

(821,692)

(1,035,991)

 

Interest expenses are presented net of the effect of interest rate derivative financial instruments which mitigate Ambev interest rate risk (Note 21 – Financial instruments and risks ). The interest expense are as follows:

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Financial liabilities measured at amortized cost

(220,633)

(221,475)

 

(105,525)

(106,034)

Liabilities at fair value through profit or loss

(554,755)

(479,977)

 

(276,339)

(242,360)

Fair value hedge - hedged items

(17,896)

(29,120)

 

(7,785)

(10,814)

Fair value hedge - hedging instruments

779

8,822

 

(13)

537

 

(792,505)

(721,750)

 

(389,662)

(358,671)

 

(b)      Finance income

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Interest income

226,423

288,779

 

117,759

103,671

Gains on derivative

3,943

114,713

 

1,933

9,513

Financial assets at fair value through profit or loss

7,609

36,234

 

(1,133)

11,854

Other financial results

8,558

18,534

 

4,311

11,070

 

246,533

458,260

 

122,870

136,108

 

Interest income arises from the following financial assets:

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Cash and cash equivalents

86,249

133,653

 

42,985

62,971

Investment securities held for trading

15,020

23,355

 

4,851

13,745

Other receivables

125,154

131,771

 

69,923

26,955

 

226,423

288,779

 

117,759

103,671

 

 

 

32


 
 

 

19.     INCOME TAX AND SOCIAL CONTRIBUTION

Income taxes reported in the income statement are analyzed as follows:

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Income tax expense - current

(1,259,055)

(1,172,401)

 

(577,296)

(533,547)

           

Deferred tax expense on temporary differences

852,635

(446,563)

 

398,510

(281,898)

Deferred tax over taxes losses carryforwards movements in the current period

(152,552)

1,055,998

 

(41,673)

588,862

Total deferred tax (expense)/income

700,083

609,435

 

356,837

306,964

           

Total income tax expenses

(558,972)

(562,966)

 

(220,459)

(226,583)

 

The reconciliation from the weighted nominal to the effective tax rate is summarized as follows:

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Profit before tax

4,973,636

5,629,480

 

2,345,292

2,399,104

Adjustment on taxable basis

         

Non-taxable income

(168,029)

(263,577)

 

(63,179)

(133,584)

Government grants related to sales taxes

(849,444)

(724,082)

 

(415,031)

(382,967)

Share of results of associates

(6,301)

(7,837)

 

(5,269)

(388)

Non-deductible expenses

30,508

464,503

 

(59,487)

204,068

Complement of income tax of foreign subsidiaries due in Brazil

44,166

92,159

 

22,083

61,144

Results of intercompany transactions non-taxable/not deductible in Brazil

(299,083)

915,919

 

(311,799)

467,943

3,725,453

6,106,565

 

1,512,610

2,615,320

Aggregated weighted nominal tax rate

28.30%

30.33%

 

26.36%

29.54%

Taxes payable – nominal rate

(1,054,274)

(1,852,043)

 

(398,726)

(772,649)

Adjustment on tax expense

 

 

 

 

 

Regional incentives - income taxes

79,022

101,451

 

50,881

49,448

Deductible interest on shareholders’ equity

653,383

1,118,698

 

368,988

425,382

Tax savings from goodwill amortization on tax books

82,573

71,122

 

46,349

35,533

Withholding tax over undistributed profits

(175,602)

(82,016)

 

(124,364)

130

Others with reduced taxation

(144,074)

79,822

 

(163,587)

35,573

Income tax and social contribution expense

(558,972)

(562,966)

 

(220,459)

(226,583)

Effective tax rate

11.24%

10.00%

 

9.40%

9.44%

 

The main events that impacted the effective tax rate in the period were:

 

§

Non-taxable net financial and other income: The movement perceived in this line is related to incomes and expenses in subsidiaries, which occurs mainly due to foreign exchange variation;

 

§

Government subsidy on sales taxes: The Company has state tax incentives within certain industrial development programs in the form of financing, deferral of tax payments or partial reductions of the amount due. Such investment subsidies arising from deferred and presumed ICMS credits are deductible for income tax purposes.

 

 

 

33


 
 

 

§

Additional income tax of foreign associates taxed in Brazil: The reduction in this line, which is related to Ambev subsidiaries foreign profits taxation in Brazil, is the outcome of a better management of our capital structure;

 

§

Results of intercompany transactions taxed/deductible in Brazil: In this line are recorded the foreign exchange variation effect and the interest generated by intercompany transactions, between companies based in different jurisdictions. The main cause of the variation is related to foreign exchange;

 

§

Deductible Interest on net equity: Under Brazilian law, companies have the option to distribute interest on equity (“JCP”), calculated based on the long-term interest rate (“TJLP”), Which are deductible for income tax purposes under the applicable legislation, which approximate amount to be distributed until now is R$1,922 million and the tax impact is R$653 million.

 

The Company has been granted income tax incentives by the Brazilian Government in order to promote economic and social development in certain areas of the North and Northeast. These incentives are recorded as income on an accrual basis and allocated at year-end to the tax incentive reserve account.

 

20.     SHARE-BASED PAYMENTS

 

There are different share-based payment programs and stock option plans which allow the senior management from the Company and its subsidiaries to receive or acquire shares of the Company . For all option plans, the fair value is estimated at grant date, using the Hull binomial pricing model, modified to reflect the IFRS 2 requirement that assumptions about forfeiture before the end of the vesting period cannot impact the fair value of the option.

 

This current model of share based payment includes two types of grants: Grant 1: the beneficiary may choose to allocate 30%, 40%, 60%, 70% or 100% of the amount related to the profit share he received in the year, at the immediate exercise of options, thus acquiring the corresponding shares of the Company, and the delivery of a substantial part of the acquired shares is conditioned to the permanency in the Company for a period of five-years from the date of exercise; Grant 2: the beneficiary may exercise the options after a period of five years.

Additionally, as a means of a creating long term incentive (wealth incentive) for certain senior employees and members of management considered as having “high potential,” the Company issue share appreciation rights in the form of phantom stocks or stocks to future delivery to those employees, pursuant to which the beneficiary shall receive two separate lots – Lot A and Lot B – subject to maturation periods of five and ten years, respectively.

 

 

34


 
 

 

In addition, the Company has implemented a Stock Based Payment Plan under which certain employees and members of the management of the Company or its direct or indirect subsidiaries are eligible to receive shares of the Company including in the form of ADR’s. The shares that are subject to the Stock Plan are designated as "Restricted Shares" and the restricted share price for the purposes of the stock plan will correspond to the price of the Company's shares on B3 S.A.- Brasil, Bolsa, Balcão, in the trading session immediately prior to the stock concession Restricted.

The weighted average fair value of the options and assumptions used in applying the A mbev option pricing model for the “Grant 2” of 2017 and 2016 grants are as follows:

 

In R$, except when otherwise indicated

06/30/2017

(i)

12/31/2016

(i)

         

Fair value of options granted

5.57

 

6.21

 

Share price

17.16

 

17.18

 

Exercise price

17.16

 

17.18

 

Expected volatility

26.8%

 

27.0%

 

Vesting year

5

 

5

 

Expected dividends

5%

 

5%

 

Risk-free interest rate

10.0%

(ii)

12.4%

(ii)

 

(i)     Information based on weighted average plans granted, except for the expected dividends and risk-free interest rate.

 

(ii ) The percentages include the grants of stock options and ADR’s during the period, in which the risk-free interest rate of ADR’s  are calculated in U.S. dollar.

 

 The total number of outstanding options developed as follows:

Thousand options

06/30/2017

 

12/31/2016

       

Options outstanding at January 1 st

131,244

 

121,770

Options issued during the period

4,336

 

24,806

Options exercised during the period

(8,212)

 

(11,613)

Options forfeited during the period

(2,099)

 

(3,719)

Options outstanding at ended period

125,269

 

131,244

 

The range of exercise prices of the outstanding options is nearly zero (R$0.02 as of December 31, 2016) and R$25.95 (R$28.32 as of December 31, 2016) and the weighted average remaining contractual life is approximately 6.28 years (5.96 years as of December 31, 2016).

 

Of the 125,269 thousand outstanding options (131,244 thousands of December 31, 2016), 44,486 thousand options are vested as at June 30, 2017 (52,780 thousands of December 31, 2016).

 

 

35


 
 

 

The weighted average exercise price of the options is as follows:

 

In R$ per share

06/30/2017

 

12/31/2016

       

Options outstanding at January 1 st

13.87

 

12.36

Options issued during the period

17.16

 

17.18

Options forfeited during the period

17.75

 

12.83

Options exercised during the period

5.07

 

2.52

Options outstanding at ended period

13.73

 

13.87

Options exercisable at ended period

3.75

 

3.66

 

For the options exercised during the period ended June 30,2017, the weighted average share price on the exercise date was R$17.89 (R$18.41 as of December 31, 2016).

 

During the period, A mbev issued 366 thousand (7,329 thousand in 2016) deferred stock units related to exercise of the options in the model “Grant 1”. These deferred stock units are valued at the share price of the day of grant, representing fair value of approximately R$6,127 on June 30, 2017 (R$133,884 on December 31, 2016), and cliff vest after five years.

The total number of shares purchased under the plan of shares by employees, whose grant is deferred to future time under certain conditions (deferred stock), is shown below:

Thousand deferred shares

06/30/2017

 

12/31/2016

       

Deferred shares outstanding at January 1 st

19,260

 

19,056

New deferred shares during the period

366

 

7,329

Deferred shares granted during the period

(2,804)

 

(6,118)

Deferred shares forfeited during the period

(686)

 

(1,007)

Deferred shares outstanding at ended period

16,136

 

19,260

 

Additionally, certain employees and directors of the Company receive options to acquire AB Inbev shares, the compensation cost of which is recognized in the income statement against equity .

These share-based payments generated an expense of R$94,547 (R$97,474 for the six-month period ended June 30, 2016), recorded as administrative expenses.

 

21.     FINANCIAL INSTRUMENTS AND RISKS

 

Risk factors

The Company is exposed to foreign currency , interest rate , commodity price , liquidity and credit risk in the ordinary course of business . The Company a nalyzes each of these risks both individually and as a whole to define strategies to manage the economic impact on Company’s performance consistent with its Financial Risk Management Policy .

 

 

36


 
 

 

The Company’s use of derivatives strictly follows its Financial Risk Management Policy approved by the Board of Directors. The purpose of the policy is to provide guidelines for the management of financial risks inherent to the capital markets in which Ambev carries out its operations. The policy comprises four main aspects: (i) capital structure, financing and liquidity, (ii) transactional risks related to the business, (iii) financial statements translation risks and (iv) credit risks of financial counterparties.

The policy establishes that all the financial assets and liabilities in each country where Ambev operates must be denominated in their respective local currencies. The policy also sets forth the procedures and controls needed for identifying, measuring and minimizing market risks, such as variations in foreign exchange rates, interest rates and commodities (mainly aluminum, wheat, corn and sugar) that may affect Ambev’s revenues, costs and/or investment amounts. The policy states that all the known risks (e.g. foreign currency and interest) shall be hedged by contracting derivative financial instruments. Existing risks not yet recorded (e.g. future contracts for the purchase of raw material or property, plant and equipment) shall be mitigated using projections for the period necessary for the Company to adapt to the new costs scenario that may vary from ten to fourteen months, also through the use of derivative financial instruments. Most of the translation risks are not hedged. Any exception to the policy must be approved by the Board of Directors .

 

Derivative financial Instruments

 

Derivative financial instruments authorized by the Financial Risk Management Policy a re futures contracts traded on exchanges, full deliverable forwards, non-deliverable forwards, swaps and options. At June 30, 2017, the Company and its subsidiaries had no target forward, swaps with currency verification or any other derivative operations representing a risk level above the nominal value of their contracts. The derivative operations are classified by strategies according to their purposes, as follows:

 

i) Cash flow hedge derivative instruments – The highly probable forecast transactions contracted in order to minimize the Company's exposure to fluctuations of exchange rates and prices of raw materials, investments, equipment and services to be procured, protected by cash flow hedges that shall occur at various different dates during the next fourteen months. Gains and losses classified as hedging reserve in equity are recognized in the income statement in the period or periods when the forecast and hedged transaction affects the income statement.

 

ii) Fair value hedge derivative instruments – operations contracted with the purpose of mitigating the Company’s net indebtedness against foreign exchange and interest rate risk. Cash net positions and foreign currency debts are continually assessed for identification of new exposures.

 

 

 

37


 
 

 

The results of these operations, measured according to their fair value, are recognized in financial results.

 

iii ) Net investment hedge derivative instruments transactions entered into in order to minimize exposure of the exchange differences arising from conversion of net investment in the Company's subsidiaries located abroad for translation account balance . The effective p ortion of the hedge is allocated to equity a nd the ineffectiveness portion is recorded directly in financial results.

 

The following tables summarize the exposure of the Company that were identified and protected in accordance with the Company's Risk Policy. The following denominations have been applied:

 

Operational Hedge: Refers to the exposures arising from the core business of Ambev, such as: purchase of inputs, purchase of fixed assets and service contracts linked to foreign currency, which is protected through the use of derivatives.

 

Financial Hedge: Refers to the exposures arising from cash and financing activities, such as: foreign currency cash and foreign currency debt, which is protected through the use of derivatives.

 

Investment hedge abroad: Refers mainly to exposures arising from cash hold in foreign currency in foreign subsidiaries whose functional currency is different from the consolidation currency.

 

Investment hedge - Put option granted on subsidiary : As detailed in Note 13 (d.4) the Company constituted a liability related to acquisition of Non-controlling interest in the Dominican Republic operations. This financial instrument is denominated in Dominican Pesos and is recorded in a Company which functional currency is the Real. The Company assigned this financial instrument as a hedging instrument for part of its net assets located in the Dominican Republic, in such manner the hedge result can be recorded in other comprehensive income of the group, following the result of the hedged item.

 

 

 

38


 
 

 

Transactions protected by derivative financial instruments in accordance with the Financial Risk Management Policy

 

 

 

 

 

 

 

 

06/30/2017

 

Six-month period ended: 06/30/2017

 

Three-month period ended: 06/30/2017

 

 

 

 

 

 

 

Fair Value

 

Gain / (Losses)

 

Gain / (Losses)

Exposure

 

Risk

   

Notional

 

Assets

Liability

 

Finance Result

Operational Result

Equity

 

Finance Result

Operational Result

Equity

                                 

Cost

   

(9,046,666)

 

8,816,281

 

249,460

(192,310)

 

(465,052)

(191,032)

264,692

 

(174,153)

(67,441)

235,055

   

Commodity

(1,840,046)

 

1,609,661

 

108,945

(136,889)

 

(2,667)

54,917

31,748

 

(2,299)

10,211

33,608

   

American Dollar

(6,798,492)

 

6,798,492

 

96,743

(53,170)

 

(460,645)

(260,777)

205,052

 

(178,014)

(104,847)

174,565

   

Euro

(86,128)

 

86,128

 

3,188

(1,874)

 

(768)

(1,196)

4,501

 

(1,170)

8,739

(2,026)

   

Mexican Pesos

(322,000)

 

322,000

 

40,584

(377)

 

(972)

16,024

23,391

 

7,330

18,456

28,908

                                 
                                 

Fixed Assets

   

(586,652)

 

586,652

 

7,520

(1,657)

 

(1,114)

-

-

 

786

-

-

   

American Dollar

(541,424)

 

541,424

 

7,520

(1,625)

 

(1,670)

-

-

 

(335)

-

-

   

Euro

(45,228)

 

45,228

 

-

(32)

 

556

-

-

 

1,121

-

-

                                 

Expenses

   

(112,942)

 

112,942

 

2,471

(1,609)

 

(2,655)

3,916

574

 

(222)

3,798

331

   

American Dollar

(99,720)

 

99,720

 

2,100

(1,445)

 

(2,524)

3,513

519

 

(116)

3,513

519

   

Rupee

(13,222)

 

13,222

 

371

(164)

 

(131)

403

55

 

(106)

285

(188)

                                 

Cash

   

1,125,286

 

(1,125,286)

 

-

(419)

 

(1,134)

-

-

 

(16,359)

-

-

   

American Dollar

1,140,286

 

(1,140,286)

 

-

(395)

 

(1,139)

-

-

 

(16,359)

-

-

   

Interest rate

(15,000)

 

15,000

 

-

(24)

 

5

-

-

 

-

-

-

                                 

Debts

   

(2,636,957)

 

2,049,800

 

27,800

(2,360)

 

(20,729)

-

-

 

51,572

-

-

   

American Dollar

(1,937,398)

 

1,350,241

 

786

-

 

(23,276)

-

-

 

51,827

-

-

   

Interest rate

(699,559)

 

699,559

 

27,014

(2,360)

 

2,547

-

-

 

(255)

-

-

                                 

Equity Instrument

   

(1,500,000)

 

330,820

 

2,175

-

 

2,175

-

-

 

2,175

-

-

   

ADR's Price

(1,500,000)

 

330,820

 

2,175

-

 

2,175

-

-

 

2,175

-

-

As of June 30, 2017

   

(12,757,931)

 

10,771,209

 

289,426

(198,355)

 

(488,509)

(187,116)

265,266

 

(136,201)

(63,643)

235,386

 

 

 

39


 
 

 

 

 

 

 

 

 

 

12/31/2016

 

Six-month period ended: 06/30/2016

 

Three-month period ended: 06/30/2016

 

 

 

 

 

 

 

Fair Value

 

Gain / (Losses)

 

Gain / (Losses)

Exposure

 

Risk

   

Notional

 

Assets

Liability

 

Finance Result

Operational Result

Equity

 

Finance Result

Operational Result

Equity

                                 

Cost

   

(8,807,524)

 

8,624,076

 

190,727

(582,809)

 

(789,765)

709,625

(1,078,446)

 

(374,741)

245,054

(512,702)

   

Commodity

(1,742,763)

 

1,559,315

 

136,502

(43,743)

 

-

(132,064)

7,783

 

-

(57,939)

-

   

American Dollar

(6,566,888)

 

6,566,888

 

36,042

(491,299)

 

(795,641)

803,190

(994,655)

 

(382,118)

287,808

(501,289)

   

Euro

(135,235)

 

135,235

 

-

(4,685)

 

7,102

41,264

(91,735)

 

8,132

15,894

(11,413)

   

Mexican Pesos

(359,191)

 

359,191

 

18,183

(43,326)

 

(1,226)

(2,765)

161

 

(755)

(709)

-

   

Brazilian Real

(3,447)

 

3,447

 

-

244

 

-

-

-

 

-

-

-

                                 

Fixed Assets

   

(523,088)

 

523,088

 

3,009

(76,101)

 

(195,003)

-

-

 

(116,767)

-

-

   

American Dollar

(430,332)

 

430,332

 

2,974

(5,814)

 

(134,536)

-

-

 

(74,328)

-

-

   

Euro

(92,756)

 

92,756

 

35

(70,287)

 

(60,467)

-

-

 

(42,439)

-

-

                                 

Expenses

   

(103,779)

 

103,779

 

824

(1,089)

 

49,238

-

(134,211)

 

(1,297)

-

4,756

   

American Dollar

(90,945)

 

90,945

 

35

(1,089)

 

(1,248)

-

(28,608)

 

(966)

-

4,756

   

Euro

-

 

-

 

-

-

 

(375)

-

688

 

(331)

-

-

   

Canadian Dollar

-

 

-

 

-

-

 

50,861

-

(106,291)

 

-

-

-

   

Rupee

(12,834)

 

12,834

 

789

-

 

-

-

-

 

-

-

-

                                 

Cash

   

1,043,872

 

(1,043,872)

 

(3)

7,841

 

76,511

-

-

 

24,873

-

-

   

American Dollar

592,341

 

(592,341)

 

(3)

7,832

 

37,254

-

-

 

12,320

-

-

   

Euro

51,531

 

(51,531)

 

-

110

 

7,954

-

-

 

315

-

-

   

Interest rate

400,000

 

(400,000)

 

-

(101)

 

31,303

-

-

 

12,238

-

-

                                 

Debts

   

(2,547,901)

 

2,000,198

 

18,424

(61,222)

 

(21,660)

-

-

 

(21,023)

-

-

   

American Dollar

(1,874,157)

 

1,326,454

 

2,576

(48,488)

 

(7,518)

-

-

 

(18,873)

-

-

   

Interest rate

(673,744)

 

673,744

 

15,848

(12,734)

 

(14,142)

-

-

 

(2,150)

-

-

                                 

Foreign Investments

   

-

 

-

 

-

-

 

(1,161)

-

35,348

 

-

-

-

   

American Dollar

-

 

-

 

-

-

 

(937)

-

37,166

 

-

-

-

   

Euro

-

 

-

 

-

-

 

44

-

1,683

 

-

-

-

   

Canadian Dollar

-

 

-

 

-

-

 

(268)

-

(3,501)

 

-

-

-

Total

   

(10,938,420)

 

10,207,269

 

212,981

(713,380)

 

(881,840)

709,625

(1,177,309)

 

(488,955)

245,054

(507,946)

 

 

40


 
 

 

I.           Market risk

 

a.1) Foreign currency risk

The Company is exposed to foreign currency risk on borrowings, investments, purchases, dividends and/or interest expense/income whenever they are denominated in currency other than the functional currency of the subsidiary. The main derivatives financial instruments used to manage foreign currency risk are futures contracts, swaps, options, non deliverable forwards and full deliverable forwards.

 

a.2) Commodity Risk

A significant portion of the Company inputs comprises commodities, which historically have experienced substantial price fluctuations. The Company therefore uses both fixed price purchasing contracts and derivative financial instruments to minimize its exposure to commodity price volatility. The Company has important exposures to the following commodities: aluminum, sugar, wheat and corn. These derivative financial instruments have been designated as cash flow hedges.

 

a.3) Interest rate risk

The Company a pplies a dynamic interest rate hedging approach whereby the target mix between fixed and floating rate debt is reviewed periodically. The purpose of t he Company ’s policy is to achieve an optimal balance between cost of funding and volatility of financial results, taking into account market conditions as well as the Company ’s overall business strategy and this strategy is reviewed periodically.

 

The table below demonstrates the Company’s exposure related to debts, before and after interest rates hedging strategy.

 

 

06/30/2017

 

Pre - Hedge

 

Post - Hedge

 

Interest rate

Amount

 

Interest rate

Amount

Brazilian Real

8.0%

894,038

 

6.3%

404,881

Working capital in Argentinean peso

24.7%

26,368

 

24.7%

26,368

Dominican Peso

9.7%

287,223

 

9.7%

287,223

American Dollar

3.6%

26,552

 

3.6%

26,552

Working Capital in Paraguayan Guarani

10.5%

693

 

10.5%

693

Guatemala´s Quetzal

7.9%

10,317

 

7.9%

10,317

Interest rate pre-set

 

1,245,191

   

756,034

           
           

Brazilian Real

9.3%

479,563

 

9.9%

2,295,279

American Dollar

1.9%

1,887,164

 

2.5%

560,605

Canadian Dollar

1.6%

1,327,810

 

1.6%

1,327,810

Barbadian Dollar

2.3%

4,969

 

2.3%

4,969

Interest rate postfixed

 

3,699,506

   

4,188,663

 

 

 

41


 
 

 

 

 

 

 

12/31/2016

 

Pre - Hedge

 

Post - Hedge

 

Interest rate

Amount

 

Interest rate

Amount

Brazilian Real

6.8%

1,223,500

 

6.2%

841,923

Dominican Peso

9.7%

288,808

 

9.7%

288,808

American Dollar

6.0%

11,561

 

6.0%

1,797

Guatemala´s Quetzal

8.0%

9,947

 

8.0%

9,947

Barbadian Dollar

4.3%

48,517

 

4.3%

48,517

Interest rate pre-set

 

1,582,333

   

1,190,992

           
           

Brazilian Real

10.0%

667,703

 

12.6%

2,375,614

American Dollar

1.5%

1,882,252

 

2.2%

565,683

Canadian Dollar

1.6%

1,259,107

 

1.6%

1,259,106

Barbadian Dollar

2.7%

4,915

 

2.7%

4,915

Interest rate postfixed

 

3,813,977

   

4,205,318

 

 

Sensitivity analysis

The Company mitigates risks arising from non-derivative financial assets and liabilities substantially, through derivative financial instruments. In this context, the Company has identified the main risk factors that may generate losses from these derivative financial instruments and has developed a sensitivity analysis based on three scenarios, which may impact the Company’s future results and/or cash flow, as described below:

 

1 – Probable scenario: Management expectations of deterioration in each transaction’s main risk factor. To measure the possible effects on the results of derivative transactions, the Company uses parametric Value at Risk – VaR. is a statistical measure developed through estimates of standard deviation and correlation between the returns of several risk factors. This model results in the loss limit expected for an asset over a certain time period and confidence interval. Under this methodology, we used the potential exposure of each financial instrument, a range of 95% and horizon of 21 days after June 30, 2017 for the calculation, which are presented in the module.

 

2 – Adverse scenario: 25% deterioration in each transaction’s main risk factor as compared to the level observed on June 30, 2017.

 

3 – Remote scenario: 50% deterioration in each transaction’s main risk factor as compared to the level observed on June 30, 2017.

 

 

42


 
 

 

Transaction

Risk

Fair Value

Probable
scenario

Adverse
scenario

Remote
scenario

           

Commodities hedge

Decrease on commodities price

(27,944)

(79,974)

(430,359)

(832,774)

Input purchase

27,944

76,426

372,762

717,581

Foreign exchange hedge

Foreign currency decrease

85,094

25,878

(1,716,561)

(3,518,216)

Input purchase

(85,094)

(25,878)

1,716,561

3,518,216

Costs effects

 

-

(3,548)

(57,597)

(115,193)

           

Foreign exchange hedge

Foreign currency decrease

5,863

1,304

(140,800)

(287,463)

Capex Purchase

(5,863)

(1,304)

140,800

287,463

Fixed assets effects

 

-

-

-

-

           

Foreign exchange hedge

Foreign currency decrease

862

183

(27,373)

(55,609)

Expenses

(862)

(183)

27,373

55,609

Expenses effects

 

-

-

-

-

           

Hedge cambial

Foreign currency increase

(395)

(10,506)

(285,467)

(570,538)

Cash

395

10,506

285,467

570,538

Interest Hedge

Decrease in interest rate

(24)

(186)

(3,707)

(4,289)

Interest revenue

24

186

3,707

4,289

Cash effects

 

-

-

-

-

           

Hedge cambial

Foreign currency decrease

786

(13,306)

(336,775)

(674,335)

Cash

(786)

7,178

189,985

380,756

Interest Hedge

Increase in interest rate

24,654

17,129

(126,749)

(148,766)

Interest expenses

(24,654)

(17,129)

126,749

148,766

Debt effects

 

-

(6,128)

(146,790)

(293,579)

Equity Instrument Hedge

ADR's price decrease

2,175

(2,278)

(80,530)

(163,235)

Expenses

(2,175)

(13,459)

(211,765)

(421,355)

Equity effects

 

-

(15,737)

(292,295)

(584,590)

   

-

(25,413)

(496,682)

(993,362)

 

 

 

43


 
 

 

As of June 30, 2017 the Notional and Fair Value amounts per instrument and maturity were as follows:

 

 

Notional Value

Exposure

Risk

2017

2018

2019

2020

>2020

Total

               

Cost

 

6,722,176

2,094,105

-

-

-

8,816,281

 

Commodity

856,383

753,278

-

-

-

1,609,661

 

American Dollar

5,649,128

1,149,364

-

-

-

6,798,492

 

Euro

24,201

61,927

-

-

-

86,128

 

Mexican Peso

192,464

129,536

-

-

-

322,000

               

Fixed asset

 

513,243

73,409

-

-

-

586,652

 

American Dollar

468,015

73,409

-

-

-

541,424

 

Euro

45,228

-

-

-

-

45,228

               

Expenses

 

83,961

28,981

-

-

-

112,942

 

American Dollar

77,575

22,145

-

-

-

99,720

 

Rupee

6,386

6,836

-

-

-

13,222

               

Cash

 

(1,140,286)

-

-

15,000

-

(1,125,286)

 

American Dollar

(1,140,286)

-

-

-

-

(1,140,286)

 

Brazilian Real

-

-

-

15,000

-

15,000

               

Debt

 

1,650,241

-

-

-

399,559

2,049,800

 

American Dollar

1,350,241

-

-

-

-

1,350,241

 

Brazilian Real

300,000

-

-

-

399,559

699,559

               

Equity Instrument

 

-

330,820

-

-

-

330,820

 

ADR's Price

-

330,820

-

-

-

330,820

   

7,829,335

2,527,315

-

15,000

399,559

10,771,209

 

   

Fair Value

Exposure

Risk

2017

2018

2019

2020

>2020

Total

               

Cost

 

104,909

(47,759)

-

-

-

57,150

 

Commodity

35,910

(63,854)

-

-

-

(27,944)

 

American Dollar

61,862

(18,289)

-

-

-

43,573

 

Euro

45

1,269

-

-

-

1,314

 

Mexican Peso

7,092

33,115

-

-

-

40,207

               

Fixed asset

 

5,995

(132)

-

-

-

5,863

 

American Dollar

6,027

(132)

-

-

-

5,895

 

Euro

(32)

-

-

-

-

(32)

               

Expenses

 

1,255

(393)

-

-

-

862

 

American Dollar

884

(229)

-

-

-

655

 

Rupee

371

(164)

-

-

-

207

               

Cash

 

(20,877)

20,482

-

(24)

-

(419)

 

American Dollar

(20,877)

20,482

-

-

-

(395)

 

Interest rate

-

-

-

(24)

-

(24)

               

Debt

 

(1,574)

-

-

-

27,014

25,440

 

American Dollar

786

-

-

-

-

786

 

Interest rate

(2,360)

-

-

-

27,014

24,654

               

Equity Instrument

 

-

2,175

-

-

-

2,175

 

ADR's Price

-

2,175

-

-

-

2,175

   

89,708

(25,627)

-

(24)

27,014

91,071

 

 

 

44


 
 

 

  II.      Credit Risk

 

Concentration of credit risk on trade receivables

A substantial part of the Company’s sales is made to distributors, supermarkets and retailers, within a broad distribution network. Credit risk is reduced because of the widespread number of customers and control procedures used to monitor risk. Historically, the Company has not experienced significant losses on receivables from customers.

Concentration of credit risk on counterpart

In order to minimize the credit risk of its investments, the Company has adopted procedures for the allocation of cash and investments, taking into consideration limits and credit analysis of financial institutions, avoiding credit concentration, i.e., the credit risk is monitored and minimized to the extent that negotiations are carried out only with a select group of highly rated counterparties.

 

The selection process of financial institutions authorized to operate as the Company’s counterparty is set forth in our Credit Risk Policy. This Credit Risk Policy establishes maximum limits of exposure to each counterparty based on the risk rating and on each counterparty's capitalization.

 

In order to minimize the risk of credit with its counterparties on significant derivative transactions, the Company has adopted bilateral “trigger” clauses. According to these clauses, where the fair value of an operation exceeds a percentage of its notional value (generally between 10% and 15%), the debtor settles the difference in favor of the creditor.

As of June 30, 2017, the Company held its main short-term investments with the following financial institutions: Banco do Brasil, Bradesco, Bank Mendes Gans, Caixa Econômica Federal, Citibank, Itaú, JP Morgan Chase, Merrill Lynch, Santander e Toronto Dominion Bank. The Company had derivative agreements with the following financial institutions: Banco Bisa, Barclays, BNB, BNP Paribas, Bradesco, Citibank, Deutsche Bank, Itaú, Goldman Sachs, JP Morgan Chase, Macquarie, Merrill Lynch, Morgan Stanley, Santander, ScotiaBank e TD Securities.

The carrying amount of cash and cash equivalents, investment securities, trade receivables excluding prepaid expenses, recoverable taxes and derivative financial instruments are disclosed net of provisions for impairment and represents the maximum exposure of credit risks of June 30, 2017. There was no concentration of credit risk with any counterparties as of June 30, 2017.

III.       Liquidity Risk

 

The Company believes that cash flows from operating activities , cash and cash equivalents and short-term investments , together with the derivative financial instruments and access to loan facilities are sufficient to finance capital expenditures, financial liabilities and dividend payments in the future.

 

 

45


 
 

 

 

IV.      Equity price risk

 

Through the equity swap transaction approved on May 16th, 2017 by the Board of Directors of Ambev, the Company, or its controlled entity, will receive the price variation related to its shares traded on the stock exchange or ADRs, neutralizing the possible effects of the stock prices’ oscillation in view of the share-based payment of the Company. As these derivative instruments are not characterized as hedge accounting they were not therefore designated to any hedge.

 

In June 2017, an exposure equivalent to R$1.5 billion in AmBev’s shares (or ADR’s) was partially hedged, resulting in a gain in income statement of R$ 2,175

 

  V.      Capital management

 

Ambev is continuously optimizing its capital structure targeting to maximize shareholder value while keeping the desired financial flexibility to execute the strategic projects. Besides the statutory minimum equity funding requirements that apply to the Company’s subsidiaries in the different countries, Ambev is not subject to any externally imposed capital requirements. When analyzing its capital structure, the Company uses the same debt ratings and capital classifications as applied in the Company’s financial statements.

 

Financial instruments

 

(a) Financial instruments categories

 

Management of the financial instruments held by the Company is effected through operational strategies and internal controls to assure liquidity, profitability and transaction security . Financial instruments transactions are regularly reviewed for the effectiveness of the risk exposure that management intends to cover (foreign exchange, interest rate, etc.).

 

 

46


 
 

 

The table below shows all financial instruments recognized in the financial statements, segregated by category :

 

06/30/2017

 

Loans and
receivables

Held for
trading

Financial assets/liabilities at fair value through profit or loss

Derivatives
hedge

Financial liabilities through amortized cost

Total

Financial assets

           

Cash and cash equivalents

8,757,342

-

-

-

-

8,757,342

Investment securities

-

94,475

8,770

-

-

103,245

Trade receivables excluding prepaid expenses

6,077,769

-

-

-

-

6,077,769

Financial instruments derivatives

-

-

29,661

259,765

-

289,426

Total

14,835,111

94,475

38,431

259,765

-

15,227,782

             

Financial liabilities

           

Trade payables and put option granted on subsidiary and other liabilities

-

-

5,388,275

-

10,609,431

15,997,706

Financial instruments derivatives

-

-

55

198,300

-

198,355

Interest-bearning loans and borrowings

-

-

-

-

4,917,636

4,917,636

Total

-

-

5,388,330

198,300

15,527,067

21,113,697

 

 

 

12/31/2016

 

Loans and
receivables

Held for
trading

Financial assets/liabilities at fair value through profit or loss

Derivatives
hedge

Financial liabilities through amortized cost

Total

Financial assets

           

Cash and cash equivalents

7,876,849

-

-

-

-

7,876,849

Investment securities

-

104,340

282,771

-

-

387,111

Trade receivables excluding prepaid expenses

6,962,541

-

-

-

-

6,962,541

Financial instruments derivatives

-

-

18,424

194,557

-

212,981

Total

14,839,390

104,340

301,195

194,557

-

15,439,482

             

Financial liabilities

           

Trade payables and put option granted on subsidiary and other liabilities

-

-

5,106,125

-

13,208,075

18,314,200

Financial instruments derivatives

-

-

49,850

663,530

-

713,380

Interest-bearning loans and borrowings

-

-

-

-

5,396,310

5,396,310

Total

-

-

5,155,975

663,530

18,604,385

24,423,890

 

(b) Classification of financial instruments by type of fair value measurement

IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

Also pursuant to IFRS 13, financial instruments measured at fair value shall be classified within the following categories :

 

 

47


 
 

 

Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date valuation;

 

Level 2 – inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable inputs for the asset or liability.

 

06/30/2017

 

12/31/2016

                   
 

Level 1

Level 2

Level 3

Total

 

Level 1

Level 2

Level 3

Total

Financial assets

                 

Financial asset at fair value through profit or loss

8,770

-

-

8,770

 

282,771

-

-

282,771

Derivatives assets at fair value through profit or loss

472

29,189

-

29,661

 

2,576

15,848

-

18,424

Derivatives - operational hedge

27,162

232,603

-

259,765

 

83,611

110,946

-

194,557

 

36,404

261,792

-

298,196

 

368,958

126,794

-

495,752

Financial liabilities

                 

Financial liabilities at fair value through profit and loss (i)

-

-

5,388,275

5,388,275

 

-

-

5,106,125

5,106,125

Derivatives liabilities at fair value through profit or loss

55

-

-

55

 

9,919

39,931

-

49,850

Derivatives - operational hedge

103,332

92,608

-

195,940

 

78,935

575,867

-

654,802

Derivatives - fair value hedge

-

2,360

-

2,360

 

-

8,728

-

8,728

 

103,387

94,968

5,388,275

5,586,630

 

88,854

624,526

5,106,125

5,819,505

 

(i) Refers to the put option granted on subsidiary as described in Note 13 d(4).

 

Reconciliation of changes in the categorization of Level 3

 

Financial liabilities at December 31, 2016 (i)

5,106,125

Acquisition of investments

7,134

Total gains and losses in the period

275,016

Losses recognized in net income

282,515

Gain recognized in equity

(7,499)

Financial liabilities at June 30, 2017 (i)

5,388,275

 

(i) The liability was recorded under “Trade payables and put option granted on subsidiary and other liabilities” on the balance sheet.

 

(c) Fair value of financial liabilities measured at amortized cost

 

The Company’s liabilities, interest-bearing loans and borrowings, trade payables excluding tax payables, are recorded at amortized cost according to the effective rate method, plus indexation and foreign exchange gains/losses, based on closing indices for each exercise.

 

If the Company had recognized its financial liabilities measured at amortized at cost, at fair value, it would have recorded an additional gain, before income tax and social contribution, of approximately R$1,537 on June 30, 2017 (gain of R$2,622 on December 31, 2016), related to Bond 2017. The other financial instruments recorded at amortized cost are similar to the fair value and are not material for disclosure.

 

The criteria used to determine the fair value of the debt securities was based on quotations of investment brokers, on quotations of banks which provide services to Ambev and on the secondary market value of bonds as of June 30, 2017, being approximately 99.49% for Bond 2017 (97.91% at December 31, 2016).

 

 

48


 
 

 

 

Calculation of fair value of derivatives

The Company measures derivative financial instruments by calculating their present value, through the use of market curves that impact the instrument on the computation dates. In the case of swaps, both the asset and the liability positions are estimated independently and brought to present value, where the difference between the result of the asset and liability amount generates the swaps market value. For the traded derivative financial instruments, the fair value is calculated according to the adjusted exchange-listed price.

 

Margins given in guarantee

 

In order to comply with the guarantee requirements of the derivative exchanges and/or counterparties in certain operations with derivative financial instruments, as of June 30, 2017 the Company held R$52.728 in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (R$486,822 on December 31, 2016).

 

Offsetting of financial assets and liabilities

 

For financial assets and liabilities subject to settlement agreements by the net or similar agreements, each agreement between the Company and the counterparty allows this type of settlement when both parties make this option. In the absence of such election, the assets and liabilities will be settled by their amounts, but each party shall have the option to settle on net, in case of default by the counterparty.

22.     COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPLLIERS, ADVANCES FROM CUSTOMERS AND OTHER

 

 

06/30/2017

12/31/2016

     

Collateral given for own liabilities

610,042

1,051,538

Other commitments

801,630

754,306

 

1,411,672

1,805,844

     

Commitments with suppliers

7,908,434

4,019,236

Commitments - Bond 2017

300,000

300,000

 

8,208,434

4,319,236

 

The collateral provided for liabilities totaled approximately R$1,411,672 on June 30, 2017 (R$1,805,844 on December 31, 2016), including R$564,897 (R$571,305 on December 31, 2016) of cash guarantees. The deposits in cash used as guarantees are presented as part of other assets. To meet the guarantees required by derivative exchanges and/or counterparties contracted in certain derivative financial instrument transactions, Ambev maintained on June 30, 2017, R$52,728 (R$486,822 on December 31, 2016) in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (Note 21 – Financial instruments and risks ).

 

 

49


 
 

 

Most of the balance relates to commitments with suppliers of packaging.

Ambev is full guarantor of the Bond 2017 in amount of R$300,000, remunerated at 9.5% per year, with semiannual interest payments and final maturity in July 2017, which was issued by Ambev International that is a 100% owned finance subsidiary of the Company.

 

Future contractual commitments on June 30, 2017 a nd December 31, 2016 are as follows:

 

 

06/30/2017

12/31/2016

     

Less than 1 year

4,367,323

3,325,724

Between 1 and 2 years

2,526,882

420,777

More than 2 years

1,314,229

572,735

 

8,208,434

4,319,236

 

23.     CONTINGENCIES

 

The Company has contingent liabilities arising from lawsuits in the normal course of its business. Due to their nature, such legal proceedings involve inherent uncertainties including, but not limited to, court and tribunals rulings, negotiations between affected parties and governmental actions, and as a consequence the Company’s management cannot at this stage estimate the likely timing of the resolution of these matters.

 

Contingent liabilities with a probable likelihood of loss are fully recorded as liabilities (Note 12 – Provisions ).

 

The Company also has lawsuits related to tax, civil and labor, for which the likelihood of loss classified by management as possible and for which there are no provisions. Estimates of amounts of possible losses are as follows:

 

 

06/30/2017

12/31/2016

     

IRPJ and CSLL

29,872,497

28,934,826

PIS and COFINS

2,423,265

1,971,048

ICMS and IPI

16,947,079

16,046,890

Labor

246,262

222,037

Civil

4,706,769

4,417,574

Others

836,974

858,075

 

55,032,846

52,450,450

 

Principal lawsuits with a likelihood of possible loss:

The significant changes in the main processes with a possible likelihood of loss in relation to those presented in the financial statements for the year ended December 31, 2016 refers to the monetary variation of the period. There was no new lawsuit individually relevant to the previous period.

 

 

 

50


 
 

 

Contingent assets

 

According to IAS 37, contingent assets are not recorded in consolidated financial statements, except when the realization of income is virtually certain.

 

24.     NON-CASH ITEMS

 

The Company carried out the following investment and financing activities not involving cash:

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

Acquisition of investments payables

-

278,602

 

-

255,594

Cash financing cost other than interests

66,661

57,667

 

60,543

14,866

Others

-

(1,565)

 

-

(1,565)

 

25.     RELATED PARTIES

Policies and practices regarding the realization of transactions with related parties

The Company adopts corporate governance practices and those recommended and/or required by the applicable law.

 

Under the Company’s bylaws the Board of Directors is responsible for approving any transaction or agreements between the Company and/or any of its subsidiaries, directors and/or shareholders (including shareholders, direct or indirect shareholders of the Company). The Antitrust Compliance and Related Parties Committee of the Company is required to advise the Board of Directors of the Company in matters related to transactions with related parties.

 

Management is prohibited from interfering in any transaction in which conflict exists, even in theory, with the Company interests. It is also not permitted to interfere in decisions of any other management member, requiring documentation in the Minutes of Meeting of the Board any decision to abstain from the specific deliberation.

 

The Company’s guidelines with related parties follow reasonable or commutative terms, similar to those prevailing in the market or under which the Company would contract similar transactions with third parties. These are clearly disclosed in the financial statements as reflected in written contracts.

 

Transactions with management members:

In addition to short-term benefits (primarily salaries), the management members are entitled to participate in Stock Option Plan (Note 20 – Share-based payments ).

 

 

 

51


 
 

 

Total expenses related to the Company’s management members are as follows:

 

 

Six-month period ended:

 

Three-month period ended:

 

06/30/2017

06/30/2016

 

06/30/2017

06/30/2016

           

Short-term benefits (i)

10,128

10,595

 

5,096

3,926

Share-based payments (ii)

16,138

19,682

 

6,956

7,757

Total key management remuneration

26,266

30,277

 

12,052

11,683

 

(i) These correspond substantially to management’s salaries and profit sharing (including performance bonuses ).

 

(ii) These correspond to the compensation  cost of stock options and restricted stocks granted to management. These amounts exclude remuneration paid to members of the Fiscal Council .

 

Excluding the above mentioned plan (Note 20 – Share-based payments ), the Company no longer has any type of transaction with the Management members or pending balances receivable or payable in its balance sheet.

Transactions with the Company's shareholders:

a ) Medical, dental and other benefits

The Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficiência (“Fundação Zerrenner) is one of Ambev’s shareholders, and at June 30, 2017 held 10.0% of total share capital. Fundação Zerrenner is also an independent legal entity whose main goal is to provide Ambev’s employees, both active and retirees, with health care and dental assistance, technical and superior education courses, facilities for assisting elderly people, through direct initiatives or through financial assistance agreements with other entities. On June 30, 2017 and December 31, 2016, actuarial responsibilities related to the benefits provided directly by Fundação Zerrenner are fully funded by plan assets, held for that purpose, which significantly exceeds the liabilities at these dates. Ambev recognizes the assets (prepaid expenses) of this plan to the extent of amounts from economic benefits available to the Company, arising from reimbursements or future contributions reduction.

The expenses incurred by Fundação Zerrenner in providing these benefits totaled R$135,640 (R$124,938 on June 30, 2016), of which R$119,536 and R$16,104 related to active employees and retirees respectively (R$107,308 and R$17,629 on June 30, 2016  related to active employees and retirees respectively).

b) Leasing

 

The Ambev, through its subsidiary BSA (labeling), has an asset leasing agreement with Fundação Zerrenner, for R$63,328 for ten years, maturing on March 31, 2018.

c) Leasing – Ambev head office

Ambev has a leasing agreement of two commercial sets with Fundação Zerrenner in the annual amount of R$3,255, maturing on January, 2020.

 

 

52


 
 

 

d) Licensing agreement

 

The Company maintains a licensing agreement with Anheuser-Busch, Inc., to produce, bottle, sell and distribute Budweiser products in Brazil, Canada, and sales and distribution agreements of Budweiser products in Guatemala, Dominican Republic, Paraguay, El Salvador, Nicaragua, Uruguay and Chile. In addition, the Company produces and distributes Stella Artois products under license to ABI in Brazil and Canada and, by means of a license granted to ABI, it also distributes Brahma’s product in the United States and several countries such as the United Kingdom, Spain, Sweden, Finland and Greece. The amount recorded was R$866 (R$1,075 on June 30, 2016) and R$164,951 (R$197,062  on June 30, 2016) as licensing income and expense, respectively.

           

Ambev has licensing agreements with the Group Modelo, subsidiaries of ABI, for to import, promote and sell products Corona ( Corona Extra , Corona Light , Coronita , Pacifico a nd Negra Modelo ) in countries of the Latin America and the Canada.

Transactions with related parties

 

 

 

 

 

 

 

06/30/2017

Current

Trade receivables (i)

Other Trade receivables (i)

Trade payables (i)

Other Trade payables (i)

Borrowings and interest payable

Dividends payables

AB InBev

374

15,158

(317,254)

(746)

-

-

AB Services

467

21,079

(15)

(5,032)

-

-

AB USA

14,037

13,816

(287,671)

(3,350)

-

-

Ambev Peru

8,672

205

(18,899)

(17)

-

-

Ambrew

-

-

-

-

-

(205,489)

Cervecería Modelo

84,714

1,704

(719,659)

(57,502)

-

-

Inbev

128

22,096

(35,139)

-

-

-

ITW International

-

-

-

(212,540)

(34,257)

(1,350,713)

Panama Holding

-

13,636

-

(1,429)

-

-

Others

1,939

2,703

(61,720)

(11,129)

-

-

 

110,331

90,397

(1,440,357)

(291,745)

(34,257)

(1,556,202)

 

(i ) The amount represents the marketing operations (purchase and sale) and the reimbursement between the companies of the group.

 

 

 

12/31/2016

Current

Trade receivables (i)

Other Trade receivables (i)

Trade payables (i)

Other Trade payables (i)

Borrowings and interest payable

Dividends payables

AB InBev

6,278

13,414

(308,866)

(687)

-

-

AB Package

-

-

(31,301)

-

-

-

AB Services

275

15,175

(10)

(3,098)

-

-

AB USA

19,737

18,623

(247,389)

(1,675)

-

-

Ambev Peru

7,095

-

(4,679)

-

-

-

Ambrew

-

-

-

-

-

(89,902)

Bogotá Beer

-

210,961

-

(210,961)

-

-

Cervecería Modelo

1,071

-

(444,080)

-

-

-

Inbev

182

17,599

(17,553)

(169)

-

-

ITW International

-

-

-

(209,385)

(30,455)

(590,937)

Modelo

32

986

(15,685)

(54,476)

-

-

Others

2,579

7,255

(6,185)

(14,441)

-

-

 

37,249

284,013

(1,075,748)

(494,892)

(30,455)

(680,839)

 

(i) The amount represents the marketing operations (purchase and sale) and the reimbursement between the companies of the group.

 

 

53


 
 

 

 

The tables below represent the transactions with related parties, recognized in the income statement:

 

 

Six-month period ended: 06/30/2017

Company

Buying / Service fees / Rentals

Sales

Royalties / Benefits

Net Finance Cost

AB USA

(149,196)

21,883

(126,281)

-

Ambev Peru

(8,469)

1,410

-

-

Cervecería Modelo

(242,846)

62

(22,061)

-

Inbev

(33,636)

-

-

-

Others

(42,707)

1,540

(15,743)

(3,338)

 

(476,854)

24,895

(164,085)

(3,338)

 

 

Three-month period ended: 06/30/2017

Company

Buying / Service fees / Rentals

Sales

Royalties / Benefits

Net Finance Cost

AB USA

(74,467)

9,868

(79,172)

-

Ambev Peru

(3,548)

458

-

-

Cervecería Modelo

(159,107)

34

(16,717)

-

Inbev

(19,647)

-

-

-

Others

(25,460)

933

(6,934)

(4,162)

 

(282,229)

11,293

(102,823)

(4,162)

 

 

 Six-month period ended: 06/30/2016

 

Three-month period ended: 06/30/2016

Company

Buying / Service fees / Rentals

Sales

Royalties / Benefits

 

Buying / Service fees / Rentals

Sales

Royalties / Benefits

AB Inbev

(9,394)

-

(18,996)

 

(6,198)

-

(3,426)

AB USA

(83,033)

26,950

(151,683)

 

(46,970)

12,456

(88,134)

Cervecería Modelo

(283,665)

380

(25,570)

 

(107,677)

278

(18,975)

InBev

(37,352)

-

-

 

(19,981)

-

-

Modelo

(33,828)

-

-

 

(25,065)

(41)

-

Others

(39,768)

-

(637)

 

(17,116)

-

(312)

 

(487,040)

27,330

(196,886)

 

(223,007)

12,693

(110,847)

 

Denomination used in the tables above :

 

Ambrew S.A. (“Ambrew”)

Anheuser-Busch InBev N.V. (“AB InBev”)

Anheuser-Busch Packaging Group Inc. (“AB Package”)

Anheuser-Busch Inbev Services LLC (“AB Services”)

Anheuser-Busch Inbev USA LLC (“AB USA”)

Bogotá Beer Company BBC S.A.S. (“Bogotá Beer”)

Compañia Cervecer Ambev Peru S.A.C. (“Ambev Peru”)

Cervecería Modelo de Guadalajara S.A. (“Modelo”)

Cervecería Modelo de Mexico S. de R.L. de C.V. (“Cervecería Modelo”)

Cervecería Nacional S. de R.L. (“Panama Holding”)

Inbev Belgium N.V. (“Inbev”)

Interbrew International B.V. (“ITW International”)

 

 

 

54


 
 

 

26.     EVENTS AFTER THE REPORTING PERIOD

On July 24, 2017, the contractual commitment related to Bond 2017 in the amount of R$314,250 was due.

 

 

55

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: August 11, 2017
     
 
AMBEV S.A.
     
 
By: 
/s/ Ricardo Rittes de Oliveira Silva
 
Ricardo Rittes de Oliveira Silva
Chief Financial and Investor Relations Officer
 
 
 
 

Ambev (NYSE:ABEV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ambev Charts.
Ambev (NYSE:ABEV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ambev Charts.